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ABSTRACT 
 
DYNAMICS OF MICROEUKARYOTES AND ARCHAEA IN THE MAMMALIAN GUT 
MICROBIOME 
Serena Dollive 
Fredrick D. Bushman 
 The vertebrate microbiome consists of the bacteria, fungi, archaea, protozoans, and 
viruses that inhabit the body at diverse locations including the skin, mouth, upper airways, 
urogenital tract, and digestive tract. These microorganisms are known to synthesize vitamins, 
interact with and tone the immune system, and dramatically affect human health. A long list of 
diseases has been associated with imbalances in commensal microbiome communities. The work 
presented in this dissertation aims to characterize the microeukaryotic and archaeal components 
of the gut microbiome through development of wet lab techniques and in silico methods, and 
apply them to the study of response to antibiotics. These methods provided a picture of the 
healthy fungal and archaeal communities in the gut, with high prevalence of the yeast 
Saccharomyces and the archaeon Methanobrevibactor, along with several other species. These 
new tools were then used to investigate the longitudinal changes that the microbiome undergoes 
when treated with heavy antibiotics. Using an antibiotic cocktail containing ampicillin, neomycin, 
vancomycin, and metronidazole in a mouse model, we found that bacterial communities were 
effectively suppressed and fungi grew out by one to two orders of magnitude. After we 
discontinued antibiotics, bacterial and fungal cell counts returned to baseline levels within one 
week, but community composition was still significantly altered. Eight weeks after cessation of 
antibiotics, fungal community composition was not significantly different from non-treated 
controls, but several mice continued to have elevated levels of yeasts that had grown out during 
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antibiotic treatment. The bacterial community composition was still significantly different from 
non-treated controls. Ultimately, this work demonstrated potentially deleterious long term effects 
of antibiotic use, and emphasizes how strong cage effects can be in mouse studies. The research 
performed in this dissertation will aid researchers looking to study all three domains of life and 
take into account the effects of commonly used antibiotics in future microbiome studies.  
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CHAPTER 1: Introduction  
 
History of Microbiome Studies 
 For over a century, microbial life has been known to live in the healthy human gut [1].  
Early methods to study the microbiome were restricted to culture based methods [2] and light 
microscopy [1].  These studies were extremely limited, because only a small fraction of bacteria 
are culturable [3]. Standard culturing methods may not detect species that are restrictive 
anaerobes or auxotrophic.  Also, culture based studies are highly biased towards species with the 
ability to grow quickly and thrive in the selection media used in a specific study [4].  Basic 
microscopic techniques often have difficulty differentiating between species with similar size and 
morphology. Advanced phylogenetic stains using Fluorescent In Situ Hybridization (FISH) are 
available, but only provide visual information about a microbial community [5]. 
 Microbial community characterization was greatly advanced by the invention of Sanger 
sequencing technology in 1977 [6], which did not have the extreme biases seen in culture based 
methods and enabled researchers to study a much larger proportion of a microbial population. 
Early studies used clone based Sanger sequencing, which provided a larger view of microbiome 
communities but was still hampered by low throughput limitations [7]. The advent of high 
throughput DNA sequencing in the mid 2000s with early next generation sequencing technologies 
such as 454 Pyrosequencing[8], Solexa sequencing [9], and SOLiD sequencing [10], enabled 
researchers to produce a large number of reads at a much lower cost than the older Sanger method 
and generated read coverages large enough to reflect the true microbial populations in diverse 
microbial communities. 
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Characterization of Microbiome Communities 
 There are several strategies used to characterize complex microbial communities.   The 
most popular method for simple analysis is amplicon based sequencing. Amplicon based 
sequencing consists of targeted amplification of a conserved, yet polymorphic region that appears 
in all members of the target clade. Ideally, the primer landing sites should be sufficiently 
conserved to match the primers and amplify without bias for different species, and the genomic 
DNA that lies between the primers must be sufficiently variable between related species to allow 
differentiation [11].  Many different genes are used for amplicon based sequencing in different 
clades. The 16S ribosomal RNA gene is used almost exclusively in bacteria [12], although other 
amplicons have been proposed [13]. The 16S rRNA and rpoB genes [14] are used in archaeal 
sequencing. The 18S rRNA gene, 28S rRNA gene, and Internal Transcribed Spacers (ITS 1 and 
2) are often used to characterize fungi [15] and protozoa [16,17,18]. Amplicon based sequencing 
allows the investigator to identify community members rigorously, but does not provide any 
details about community gene content more broadly. 
 Shotgun metagenomic sequencing has become increasingly popular for characterizing 
microbiome communities. Metagenomic sequencing of communities is performed similarly to 
genome sequencing: DNA is extracted, shredded, and sequenced [19]. Once sequencing is 
complete, data is assembled into contigs through traditional genome assembly methods [20] or 
specialized methods, such as de Bruijn graph assembly [21] or binning with self organizing maps 
[22].  Data can be analyzed to determine which genes and metabolic capabilities are present in a 
community. Nevertheless, taxonomic attribution is difficult with shotgun sequencing, because 
many of the genes found may not be present in available databases. Some researchers use 16S 
genes mined from sequencing data to estimate the relative abundance of species [19]. Others have 
proposed using many phylogenetic markers simultaneously to calculate the relative abundance of 
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species found [23]. Even with improved classification methods, a bias against the detection of 
rare community members still exists. In recent years, shotgun sequencing has become 
increasingly popular with increases in read length and throughput in Solexa sequencing [19], 
which enables better sample coverage and more thorough community characterization. 
 Recently sequencing of bulk RNA (RNA-Seq) from microbiome samples has become 
popular [24]. Such studies allow researchers to determine which genes are being actively 
transcribed within a microbial community, which is not possible with DNA sequencing. These 
studies can elucidate community dynamics and help determine which community members are 
responsible for metabolic activities [25]. Despite these useful insights, RNA-Seq does offer new 
bioinformatic challenges. RNAs cannot be assembled into large contigs like genomic DNA: reads 
are often mapped back to reference genomes, and analysis quality is more dependent on the 
number and quality of reference genomes [26].    
The Gut Microbiome  
 The microbiome consists of the bacteria, archaea, fungi, protozoa, and viruses that live on 
and in the human body. It is estimated that microbial cells outnumber human host cells by 10 to 1 
[27], and the cumulative gene content is approximately 3.3 million protein coding genes [19].  
Commonly studied body sites include the mouth [28], skin [29], upper airways [30], urogenital 
tract [31], and digestive tract [32].   Different body sites have been documented to contain unique 
communities [33],  mostly attributable to differences between sites such as pH, oxygen content, 
salinity, temperature, nutrients available at the site, and other factors [33,34,35,36]. 
The digestive tract is of particular interest, because it contains the majority of commensal 
microbiome cells [19]. A majority of the host immune system cells line the digestive tract and 
interact with the microbiome [37].  Furthermore many digestive diseases such as Crohn’s disease 
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[38], ulcerative colitis [39], inflammatory bowel disease [19,40], colorectal cancer [41], and 
Clostridium difficile infection [42] have been associated with disruptions in the gut microbiome. 
Interestingly, a wide spectrum of non-digestive diseases including diabetes [43], obesity [32], 
liver diseases [41], rheumatoid arthritis [44], and autism [45] have also been associated with 
changes in the microbiome as well.  
Each unique section of the digestive tract has a distinct community [46,47].  pH [47], bile 
salt type [27], and oxygen content [48] all vary in different digestive organs, shaping the contents 
of the microbial communities. Commonly, stool samples are used to study the gut microbiome, 
because they are less invasive than collection methods using an endoscope or surgery, and have 
been documented as an adequate surrogate for the communities of the lower gastrointestinal tract 
[49]. 
Most gut microbiome studies have been restricted to analyzing the bacterial communities 
exclusively. This is due to the fact that the majority of microbiome cells are bacterial [50] and 
robust characterization methods for bacteria have been developed [49].  Several sets of primers 
targeting the bacterial 16S are widely used [51]. There is no single core bacterial community in 
the gut, but more recent analysis has revealed the presence of enterotypes: sets of specific bacteria 
that co-occur in individuals [52].  The initial enterotype study proposed three unique enterotypes 
[52], but others have postulated the existence of only two [53]. The two accepted enterotypes are 
dominated by Prevotella and Bacteroides, respectively. The more controversial third enterotype is 
postulated to be dominated by Ruminococcus [52]. All three enterotypes perform core 
microbiome functions including vitamin synthesis, energy regulation, and conditioning the host 
immune system [54]. Regardless of the enterotype, the gut bacterial community consists primarily 
of Bacteroidetes and Firmicutes [55]. Proteobacteria are common but a minority component 
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[33]. Several other phyla including Actinobacteria and Fusobacteria appear at very low levels as 
well [41]. 
Fungi  
 The fungi are a distinct group of micro- and macro-eukaryotes. Both fungi and animals 
are members of the opisthokonts, which are characterized by a single flagellum [56] and 
conserved insertions in elongation factor-1α and enolase, and supported by several single gene 
phylogenies [57]. Fungi have organelles and cell metabolism similar to those in animals, and the 
yeast Saccharomyces cerevisiae is often used as a model organism to study genetics and 
molecular biology for insights into human biology [57]. Nevertheless, fungi contain a rigid cell 
wall structure, which is not seen in animals [58]. Fungal cell walls consist of layers of mannan, β-
glucan, and chitin in different configurations across fungal species and are difficult to lyse with 
traditional DNA extraction methods [59].  Many fungal species have variable ploidy. Many 
species have haploid, diploid, and polyploid states [60] and genders or mating types within the 
haploid state [61]. Also, some fungal species can be multinucleated [62,63].  Fungi have been 
observed in nearly all environments with which human come into contact. They can live in soil 
[64], water [65], and inside living organisms [66], and can become airborne [67]. 
Fungi and the Microbiome 
 Pathogenic fungi are a public health problem and have become increasingly so in the past 
several decades with increases in susceptible populations. Specifically, patients with diseases 
such as HIV/AIDS [68] and hematological cancers that weaken the immune system [69]  are at 
elevated risk. Similarly, patients that have had solid organ [70,71] or bone marrow transplants 
[72], antibiotic exposure [73], antifungal exposure [73], received systemic corticosteroids [74], or 
used a catheter [73] are also at risk.  Many fungi can cause invasive fungal infections such as 
Candida, Aspergillus, Cryptococcus, Histoplasma, Mucor, and Coccidioides spp., among others 
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[75,76,77]. Infections can be local and relatively minor, as seen in some cutaneous infections 
[78], but many are severe and widespread as in fungal pneumonia [79] or invasive systemic 
infection [80]. Fungal infections are particularly serious because they have a higher mortality 
rate, over a third of cases in some studies [81,82]. Recently, epidemiologists have seen the rise of 
strains of Candida [83], Aspergillus [84], and Cryptococcus spp. [85] that are resistant to 
commonly used azole drugs.  These isolates are a growing health concern, especially because the 
populations of susceptible patients have been increasing [86]. 
 Fungi also inhabit the human body as commensal microbes without causing disease. 
Candida spp.  have been found in the gut of a majority of humans with culture based methods, 
and  early sequencing methods indicated that  more uncultured fungi are present [87]. The 
majority of fungal cells on the skin are Malassezia spp., but culture based evidence suggests that 
several other species inhabit the skin including Debaryomyces  and Cryptococcus spp. [29]. 
Culture independent methods indicate that a large diversity of species occupy the oral cavity, 
including Candida and Cladosporium spp. [88].  Commensal fungi usually do not cause acute 
infection, but in some instances have been linked to disease severity. In patients with ulcerative 
colitis, the presence of Candida has been associated with increased disease severity in specific 
host genotypes [39].  Outgrowth and infection of commensal Candida commonly occurs when 
non-pathogenic yeast forms grow hyphae and invade local tissue. Differences between the host 
response to yeast and hyphal states are not well understood, but the host immune system 
recognizes the fungal cell wall as a pathogen-associated molecular pattern (PAMP) and has 
specific receptors, including Dectin-1 and Dectin-2, that detect and respond to fungi [89]. 
Protozoa  
 The Protozoa consist of a diverse paraphyletic group of single celled and multicellular 
organisms spanning the domain Eukarya. Protozoa contains many high level groups, including 
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rhizaria, amoebozoa, alveolata, stramenopiles, and excavates [57].   Protozoan organisms are 
highly diverse. While all protozoa contain the same basic eukaryotic cell structure, many species 
have evolved specialized organelles [90,91,92].  Determination of the protozoal and the 
eukaryotic phylogeny has proven difficult, and numerous arrangements of high taxonomic levels 
and rootings have been proposed in recent years [57,93,94]. 
Protozoa and the Microbiome 
 Many protozoan species are human pathogens and the cause of public health problems in 
developing and tropical nations [95].  Many Protozoan diseases such as leishmania [96], malaria 
[97], Chagas disease [98], and African sleeping sickness [99] are blood borne pathogens that are 
transferred through an insect vector and cause millions of deaths and hundreds of millions 
illnesses annually [100]. Other protozoan pathogens have an oral route of infection: Giardia 
[101], Entamoeba [102], Blastocystis [103], and Balantidium [104]  and cause gastrointestinal 
disease. 
 Protozoans have also been documented to live in the gut microbiome without causing 
disease. Several species of amoeba [105] along with recognized pathogens like Giardia [106] and 
Blastocystis  [107] have been found to live commensally in the gut. Nevertheless, it is generally 
believed that commensal protozoans are a minority community component. Commensal 
Blastocystis and fungi far outnumber other microeukaryotes [108].  Nevertheless, further studies 
are needed to understand the occurrence and role of non-fungal microeukaryotes in the gut 
microbiome in health and disease.  
Archaea 
The archaea are a unique domain of prokaryotic life more closely related to eukaryotes 
than to bacteria [109]. Even though members of the archaea were known and isolated in the 
8 
 
1930s [110], archaeal species were initially classified within bacteria [111] and were not 
recognized as belonging in a clade apart from bacteria until 1977, when Carl Woese proposed that 
archaea were a distinct lineage through phylogenetic analysis of 16S ribosomal (rDNA) 
sequences [112].  Currently, there are two main archaeal kingdoms consisting of the majority of 
known species: Euryarchaeota and Crenarchaeota [113]. Additional kingdoms have been 
proposed to accommodate fringe species such as Nanoarchaeota (consisting of the species 
Nanoarchaeum equitans) [114] and Korarchaeota [115,116] (consisting of Korarchaeum 
cryptofilum)[117]. Recent phylogenetic analysis of sequenced archaeal genomes has led to the 
proposal of a third main kingdom: Thaumarchaeota, consisting of mesophilic species formerly 
classified within Crenarchaeota [118]. More deep branching archaeal kingdoms have been 
proposed as recently as 2011 [119], and the taxonomic and phylogenetic structure of the archaea 
and its exact relation to the Eukarya are still debated [120]. 
Cellular analyses of archaea have revealed that the domain has a unique cell structure and 
distinct metabolic capabilities. For example, the cell wall architecture is diverse across archaeal 
clades but significantly different from the bacterial cell wall [121], often difficult to lyse [122], 
and believed to be widely resistant to the enzyme lysozyme [123].  Additionally, archaea have 
even evolved exclusive cell wall structures such as the cannulae and hami [121], and archaeal 
membranes consist of ether linked lipids instead of ester linked lipids [124]. Methanogenesis is 
exclusive to the archaea and requires a complicated cascade of enzymes [125].  Similarly, several 
archaeal species have been documented to use highly modified enzymatic pathways in central 
glycolysis reactions [126]. The archaea are truly a separate clade from bacteria, confirmed by 
structural and biochemical distinctiveness. 
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Archaeal Detection in Environmental Samples 
Archaea have been found in a wide range of environments and commonly contain 
specific adaptations for their environment. Several species have been found in extremely hot and 
acidic environments [127,128]. These organisms have evolved heat and acid resistant enzymes 
[129], long, branched, and highly saturated membrane lipids [124], and proton pumps to keep the 
pH within the cell up to 5 orders of magnitude lower than the exterior environment [130]. 
Conversely, archaea have been found in psychrophilic environments below 0°C and are believed 
to be able to survive at lower temperatures [131]. These archaea adjust to cold temperatures by 
having a cell membrane consisting of less saturated lipids [124] and reducing the use of charged 
amino acids [132]. Archaea have also been found in hypersaline environments such as the Dead 
Sea [133] and the Great Salt Plains [134]; these archaeal species contain enzymes adapted for 
activity in saline environments [135]. In addition to extreme environments, archaea are 
commonly found in more mesophilic environments such as freshwater lakes [136], sea water 
[137], wetlands [138], and soil [139]. 
Archaea in the Gut Microbiome 
 In addition to residing in most environmental locales, archaea have been documented to 
live commensally in the microbiome. Methanobrevibacter smithii has been long considered to be 
the dominant archaeon in the human gut [50,140], living in a majority of humans [122,141]. M. 
smithii is believed to complete energy harvesting by absorbing CO2 produced by other microbes 
and converting it to methane [142]. Furthermore, the presence of M. smithii is enriched in the 
Ruminococcus-containing enterotypes [52] . Other species within the Methanobrevibacter genus 
have been detected in non-human primates [143], ruminants [144], and termites [145].  
Additionally, methanogens related to Methanobrevibacter have been found in primates [143], 
swine [146], and cockroaches [147]. 
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 Archaea in the gut are much less diverse than the bacterial inhabitants. Often M. smithii is 
the only archaeal species detected [140], and the M. smithii population usually exhibits limited 
genetic diversity. In some cases it appears almost clonal in metagenomic assemblies [50]. Several 
other archaeal species such as Methanosphaeara stadtmanae [122] and Methanomassiliicoccus 
luminyensis [148] have been detected in lower percentages in humans as well. 
Classification of Amplicon Based Sequencing Data 
The use of amplicon based sequencing creates datasets often containing similar 
sequences that need to be differentiated and binned by similarity into Operational Taxonomic 
Units (OTUs). Each OTU represents a species within the sequenced microbial community [149]. 
From each OTU a representative sequence is chosen. A representative sequence can be chosen by 
length, identity to other sequences, frequency within the OTU, or at random [150]. After a set of 
representative sequences is generated over sequencing data, the representative sequences are put 
through a classifier developed for the sequenced amplicon. 
16S Classification 
 The most popular method to classify 16S bacterial and archaeal sequences is through 
naïve Bayesian k-mer classifiers. k-mer classifiers work by generating every possible k-length 
word in a query sequence and then comparing the frequency of each k-mer in the query to k-mer 
distributions in each of the genera represented in a reference database. Each possible k-mer has its 
own word specific prior based on its frequency of occurrence in the database, which is in turn 
used to calculate the probability of observing a k-mer in a given genus. The probability of a query 
belonging to a genus is calculated by multiplying together all the probabilities of observing each 
of its k-mers in the genus. This value is computed across all genera, with a naive prior. That is, no 
genus is deemed more or less likely to contain the query sequence prior to computation. The 
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genus with the highest probability is assigned to the query sequence [151]. Classifications to 
lower taxonomic levels are possible, but most current implementations classify to the genus level. 
   Different k-mer lengths have been used in different implementations. The RDP 
classifier uses 8-mers, because 8 and 9-mers had superior accuracy in initial tests compared to 6 
and 7-mers, and 8-mers are more memory efficient [151]. Greengenes uses a 7-mer classifier, but 
allows for classifications down to the species level [152,153]. This method has been thoroughly 
vetted through “leave one out” testing of defined curated references and found to be robust [151]. 
Other classification methods relying on BLAST [150] and sequence placement within a reference 
phylogeny [154] have also been used for 16S taxonomic attribution, but k-mer classifiers are 
preferred because of their accuracy, speed, and lower susceptibility to misclassifications caused 
by errors within the reference database. Several large software packages have been published 
incorporating multiple classifiers and other statistical and phylogenetic tools for analysis of 16S 
sequences [150,154,155]. 
18S and ITS Classification 
 Classification of commonly used eukaryotic amplicons is much more difficult than 
classification of prokaryotic 16S sequences. The eukaryotic taxonomy is currently in a state of 
flux. In the past decade many new genera have been proposed and rearranged, many of which 
contain species found in the gut microbiome [156,157,158]. Furthermore, taxonomies have 
undergone major rearrangements up to the phylum level in fungi [159,160] and up to the kingdom 
level in protozoa [57,161].  Worse yet, until recently it was commonly accepted practice for a 
single fungal species to have different names based on its morphology and mating state [15]. 
Upon recent examination, up to 16 taxonomic names have been found to belong to a single 
species [162]. This redundant naming process was discontinued in 2011 [163], but many 
databases still contain outdated names. 
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 As in prokaryotes, ribosomal genes are utilized for amplicon based sequencing, but 
unlike in prokaryotes, several different genes are commonly used. The 18S ribosomal subunit, the 
eukaryotic homolog to the prokaryotic 16S rRNA gene, is popular and there are large curated 18S 
databases available [164], but the 18S gene is too conserved for consistent differentiation below 
the family level. Like the 18S, well curated resources exist for the 28S rRNA gene. The 28S 
rRNA is more variable than the 18S gene, but the Internal Transcribed Spacers (ITS) 1 and 2 
offer the best species level resolution and identification, particularly for fungi [15]. Several 
groups have used k-mer classifiers for fungal 18S and 28S rRNA genes [150,165]; however 
databases are still small compared to bacterial references, and the ITS1 and ITS2 genes are too 
variable for k-mer classifiers. Also, phylogenetic tree insertion methods using have been used on 
the 18S and 28S genes [154], but they are vulnerable to misclassified sequences in the reference 
set and similarly are not feasible for the ITS1 and ITS2 genes. Subsequently, many researchers 
have turned to using manually curated BLAST results to classify ITS sequences [39,88]. 
Antibiotics 
 Human use of antibiotics has a long history. Evidence of antibiotic use dates back to 
antiquity when ancient Nubians, Greeks, and Chinese used antibiotic laced compounds 
therapeutically [166,167,168]. More recently, antibiotics were studied in several laboratories in 
the late 19
th
 century [169] and were characterized and adapted for clinical use by Alexander 
Fleming in 1929. Antibiotics were immediately hailed as a wonder drug for previously incurable 
or untreatable bacterial infections [170]. Antibiotics are in use today across the globe as 
treatments for a wide range of infections [171]. 
Antibiotic drugs work by exploiting differences in cellular structure or metabolism between 
humans and an infecting pathogen. Many bactericidal antibiotics such as β-lactams [172] target 
bacterial cell wall synthesis and maintenance. Others, like aminoglycosides [173] and 
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tetracyclines [174], disrupt bacterial protein synthesis. Sulfonamides specifically target folate 
synthesis [175]. Like antibacterial agents, antifungal agents exploit differences in fungal and 
human cellular biology. However, fungal cells are much more similar to human cells than 
bacterial cells, and there are fewer workable drug targets. Azoles target lanosterol 14 α-
demethylase, which is a necessary enzyme in cholesterol synthesis. Polyene antifungals create 
pores in fungal cell membranes. Development of new classes of antibacterial and antifungal 
agents is ongoing [176]. 
Side effects of antibiotics can range from relatively mild gastrointestinal dysfunction to serious 
hematological, cardiac, pulmonary, hepatic, nephritic, and neurological problems[177].  
Furthermore, repeated exposures to antimicrobial agents have led strains of many important 
pathogens, such as Escherichia coli [178], Clostridium difficile [179], and Mycobacterium 
tuberculosis [180], to become drug resistant and difficult to treat.  
 Ingested and intravenous antibiotics have been demonstrated to dramatically affect the 
composition of the gut microbiome community [34]. Treatment for a bacterial infection or 
prophylaxis does not just quash the offending pathogen. Dramatic microbiome and phenotypic 
changes have been observed in mice [181] and swine [182] treated with even subclinical doses.  
Further study is required in order to determine the long term effects of antibiotic use on human 
gut health. Antibiotics have been proposed as a possible mechanism to treat disease related to the 
gut microbiome, because they are clinically tested and proven to alter the gut community [34].  
Several narrow spectrum antibiotics have been proposed as treatments for bacteria like C. difficile 
in order to avoid altering surrounding flora as a means of preserving commensal bacteria and 
health of the host [183].  
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Motivation and Thesis Outline  
The gut microbiome plays a central role in human health. However, at the start of this thesis 
project there existed methods mainly focused on characterizing the bacterial gut flora. It is known 
that the bacteria in the gut interact biochemically with archaea and microeukaryotes; therefore, 
studying bacteria in isolation provides an incomplete view of the gut community. One of the 
primary goals of this work was to pioneer methods to characterize these important communities. 
In Chapter 2, I present a sample-to-analysis pipeline to sequence fungal and microeukaryotic 
communities from human stool. This work analyzes the effectiveness of established primers and 
novel primers, developed by Greg Peterfreund in the Bushman Laboratory, and describes a 
classifier that I developed for classifying reads generated from those primers.  In Chapter 3, I 
introduce a method for successfully amplifying the archaeal 16S gene from stool samples, while 
avoiding non-target DNA. Finally, in Chapter 4, I study the longitudinal effects of antibiotic 
treatment in the gut microbiome using a mouse model. This study analyzes both the bacterial and 
microeukaryotic communities during and after antibiotic treatment. Finally, Chapter 5 describes 
the impact of this work and the new possibilities that it enables. 
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CHAPTER 2: A Sample-to-Analysis Pipeline for Analysis of 
Microeukaryotes in Human Stool  
 
The contents of this chapter have been published in:  
Dollive S, Peterfreund GL, Sherrill-Mix S, Bittinger K, Sinha R,  Hoffmann C, Nabel 
CS, Hill DA, Artis D, Bachman MA, Custers-Allen R, Grunberg S, Wu GD, Lewis 
JD, Bushman FD. (2012). A tool kit for quantifying eukaryotic rRNA gene sequences 
from human microbiome samples. Genome Biol 13: R60. 
 
2.1 Abstract 
Here we present a pipeline for analysis of deep sequencing data on single cell eukaryotes.  
We designed a new 18S rRNA gene specific PCR primer set and compared a published rRNA 
gene internal transcribed spacer (ITS) gene primer set.  Amplicons were tested against 24 
specimens from defined eukaryotes and eight well-characterized human stool samples.  A 
software pipeline (https://sourceforge.net/projects/brocc/) was developed for taxonomic 
attribution, validated against simulated data, and tested on pyrosequence data.  This study 
provides a well-characterized tool kit for sequence-based enumeration of eukaryotic organisms in 
human microbiome samples.  
2.2 Introduction  
 Many microbiome studies are limited to characterizing the bacterial components, because 
bacteria are the largest microbial component of the microbiome, changes in the bacterial 
community have been associated with many diseases [1], and robust methods to characterize 
bacteria have been vetted and standardized [2]. Nevertheless, single cell eukaryotes form an 
important part of microbiome communities, but enumerating community membership and 
proportions in complex mixtures remains challenging.  Advances in sequencing technology and 
bioinformatics have made possible several strategies.  Shotgun metagenomics, in which all DNA 
from a sample is sequenced, can yield data on the types of organisms and genes present in a 
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mixed community.  However, in many types of microbiome samples, eukaryotic microbes are a 
minor component, so shotgun metagenomics can be inefficient and expensive for their 
identification.  Target gene sequencing can yield detailed information on community membership 
efficiently, as with the 16S rRNA gene amplicons widely used for profiling bacterial 
communities.  However, there are no universally conserved regions in eukaryotic genomes 
analogous to those in the 16S rRNA locus of bacteria that yield similarly low level classifications.  
For microbiome samples from the digestive system, the potential masking effects of food DNA 
provides another complication, and for many sample types host DNA can also interfere.  
 Many diseases are mediated by infections of single cell eukaryotes [3,4,5], including 
infections of the gut [6], skin [7], urogenital tract [8], and pulmonary system [9].  In some cases 
infections have been associated with alteration of the normal microbiome [10], as in oral thrush 
[11] and aspergillosis [12], while others are apparently caused by invasion by a single eukaryotic 
pathogen such as Mucor [12] or Giardia [13].  Thus better understanding of the dynamics of 
eukaryotic components of microbiome communities will help in understanding and treating many 
of these infections. 
 Eukaryotic rRNA genes and their associated transcribed spacers have been used as 
marker genes [14,15,16,17], though target amplicons are not fully universal.  In eukaryotes, the 
18S, 5.8S, and 28S ribosomal subunits are encoded in a single locus separated by the first and 
second internal transcribed spacers (ITS). The ITS RNAs are degraded shortly after transcription 
and are not incorporated into the ribosome [18], thus ITS RNAs are less conserved than the 18S 
and 28S RNAs.  Previously developed eukaryotic rRNA gene amplicons can query these regions, 
but most have not been designed or vetted for use specifically in human microbiome studies. 
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 Here we describe a pipeline based on rRNA gene amplicons for analysis of eukaryotes of 
the human microbiome by deep sequencing.  Sequencing 18S rRNA genes could be confounded 
by the potentially more abundant rRNA gene sequences from the mammalian host or, in samples 
from the gastrointestinal tract, from food.  We thus designed an 18S rRNA gene amplicon that 
avoids mammalian and plant sequences, and also compared a published ITS1 amplicon targeting 
fungi [16].  We developed a flexible software pipeline (BROCC) for attributing sequences that 
was tailored for use with the complex and sometimes inconsistent taxonomic assignments 
characteristic of single cell eukaryotes.  Because some fungi can be hard to lyse, we compared 
four methods for lysis and DNA purification.  Performance was tested over 24 DNA samples 
from known eukaryotes and eight human stool samples.  No single marker gene strategy can 
quantify all eukaryotic sequences in a sample, but the methods described here allow 
characterization of a large and well-characterized subset. 
2.3 Materials and Methods 
Sample Collection 
 Isolates of Aspergillus, Candida, Penicillium, Cryptococcus, and Dematiaceous mold 
were obtained from the Clinical Microbiology Laboratory at the Hospital of the University of 
Pennsylvania.  Cultures were treated at 95 
o
C for five min to sterilize before removal from the 
laboratory.  The Pneumocystis, Coccidioides, Leishmania, Toxoplasma, Plasmodium, 
Arabidopsis, Saccharomyces and human samples were from lab strains at the University of 
Pennsylvania.  The samples were bead-beaten for 1 min, heat inactivated for 5 min at 95
o
C and 
then DNA was extracted with the Qiagen Stool DNA Kit using the manufacturer's protocol. DNA 
extraction for these isolates was performed by Rebecca Custers-Allen.  In subsequent studies we 
have found that the Qiagen Stool Kit is not DNA free (data not shown), explaining the origin of 
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some of the background sequences.  The human stool samples were from healthy adults described 
in [2,19]. 
Primer design 
 Greg Peterfreund designed the 18S_0067a_deg primer by screening a set of aligned 
eukaryotic 18S rRNA gene sequences downloaded from the Silva database [20] and searching for 
mammal-specific polymorphisms in the 5' conserved regions that flank the hypervariable regions. 
Three bases at 65-67 were conserved in nearly all 18S rRNA gene but were absent in mammalian 
18S rRNA genes, providing the basis for designing selective primers. The NSR399 primer was 
obtained from the European Ribosomal RNA Database. The ITS amplicons were amplified with 
the ITS1F/ITS2 primers as in Ghannoum et al [16]. 
DNA purification 
 DNA was purified from human stool (stored frozen at -80°C) using four different 
methods as specified by the manufacturer except where noted. Approximately 220mg of stool 
was used for each extraction. Human stool samples were extracted by Stephanie Grunberg. 
 The FastDNA extractions were done with the FastDNA kit as described by Ghannoum et 
al[16], except the FastPrep Instrument was replaced by a BioSpec Mini-Beadbeater-16.  The 
archaeal extractions were preformed according to the methods of Dridi et al.[21].  The PowerSoil 
extractions were bead beaten for 1.5 min in MoBio garnet tubes and centrifuged at 1500 rcf for 5 
min. 1mL of supernatant was transferred to a PowerBead Tube and heated at 65°C for 10min and 
then 95°C for 10min. We then used the manufacturer’s protocol, skipping the first sample vortex 
(steps 1 and 2) and spun for 2 min instead of 1 at the spin filter loading step (step 15). The 
samples that were purified with the PSP extraction method were placed in Lysing Matrix E tubes 
(MP Biomedical) with 1400 μl of stool stabilizer from the PSP kit and were bead beaten in a 
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Mini-BeadBeater-16 (BioSpec). Samples were then heated at 95°C for 15 minutes, placed on ice 
for 1 minute, and spun down at 13400g for 1 minute. The supernatant was then transferred to the 
PSP InviAdsorb tubes and the rest of the protocol for the PSP Spin Stool DNA Plus was followed 
according to the manufacturer’s instructions.  As controls, DNA free water was passed through 
each DNA extraction procedure, amplified, and samples were sequenced even in cases where no 
DNA was detectable after amplification ("water controls" Figure 2-5). 
Sequence acquisition 
 Primers with 12 base barcodes were used for 454 FLX sequencing. DNA was initially 
amplified with AccuPrime DNA polymerase and buffer 2 (Invitrogen). The PCR was carried out 
with a 5 min denaturing step at 95°C, followed by 35 cycles of a 45 sec denaturing step at 95°C, a 
45 sec annealing step at 56°C, and a 1.5 min extension step at 72°C. Finally, there was a 10 min 
extension step at 72°C and samples were held at 4°C.  The resulting amplicons were then 
sequenced on a Roche 454 Junior instrument using the FLX Titanium chemistry according the 
manufacturer’s instructions.  
Bioinformatic analysis 
 Raw sequence data was denoised and analyzed using the QIIME pipeline [22]. OTUs 
were formed by CD-HIT [23]at 99% convergence for the 18S rRNA gene amplicon and 95.2% 
convergence for the ITS1 amplicon. The last 20 bases in reads from the 18S rRNA gene 
amplicons were trimmed due to low overall quality. Homopolymer limits in the read quality 
filtering were disabled for the ITS1 amplicon. 
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The BROCC classifier  
 BROCC classifies query sequences by voting on BLAST hits scored by identity. All hits 
are filtered for identity and coverage. Classifications are voted on in a bottom up fashion, starting 
at the species level. Specific identity filters are specified by the user for the genus and species 
level in addition to the main identity filter used for all other levels.  Once a classification is made 
at a given level, all the higher levels are called automatically. If a consensus is not reached at a 
given level, that level and lower levels are left blank in the final classification. Genus and species 
identity filters were set at 83.05% and 95.2% for the ITS1 amplicon and 96% and 99% for the 
18S rRNA gene amplicon. All other levels were filtered at 80%. The minimum coverage and 
generic classification filters were set at 70% for all amplicons. Classifications at the species 
through family level required a 60% majority to be accepted. Classifications at the order level and 
above required a 90% majority to be accepted. The BROCC program is implemented in Python 
version 2.7. It queries the NCBI taxonomy and requires local installations of MySQL and 
BLAST. The online BLAST user interface was used in error checking.  
2.4 Results 
DNA from food is detectable in fecal material 
 Humans consume other eukaryotes as food, so in order to design maximally useful 
amplicons for the detection of eukaryotic rRNA gene sequences in gut microbiome samples, we 
first investigated the survival of DNA during passage through the gut.  In an early study of this 
issue, plasmid DNA was fed to mice and low molecular weight DNA from pellets was found to 
contain apparent plasmid-derived DNA, which was detected as smears on Southern blots [24].  
Another study showed that 16S rRNA gene sequences in pellets of gnotobiotic (germ-free) mice 
resembled 16S sequences in mouse food [25].  Our own evidence from shotgun metagenomic 
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studies also suggested that DNA from food may be detectable in human stool [19], though this 
has not been studied in detail.  In a further study (data not shown), we gavaged mice with purified 
bacterial plasmid DNA and showed that plasmid DNA could be detected in fecal pellets six hours 
but not 60 hours after feeding using Taqman Q-PCR.   Based on these observations, we sought to 
identify eukaryotic rRNA gene amplicons that could detect single cell eukaryotes of the human 
microbiome while selectively avoiding amplifying rRNA genes from food organisms and host. 
Design of amplicons 
 We targeted the 18S rRNA gene (Figure 2-1A) due to its high conservation among 
eukaryotes [26] and the substantial bioinformatic resources available for 18S rRNA gene analysis 
[20,27]. We analyzed 18S rRNA gene sequences from the Silva database [20] and manually 
scanned alignments for mammalian and plant specific polymorphisms.  A primer was designed by 
Greg Peterfreund and analyzed in silico for specificity by Scott Sherrill-Mix  (18S_0067a_deg; 
Figure 2-1B and C) that showed low edit distance (high identity) to 18S rRNA genes of Fungi, 
Amoebozoa, Chromalveolates, Rhizaria, and most excavates, but showed lower identity to human 
18S rRNA genes due to mismatches at the 3’ end.  In addition, some though not all plants showed 
relatively high edit distance to 18S_0067a_deg  (Figure 2-1B and C) . It was paired with the 
universal NSR399 18S rRNA gene primer, which is complementary to all eukaryotic clades [28].  
  The 18S rRNA gene is not sufficiently polymorphic for classification of some groups at a 
low taxonomic level [17], so we also tested an ITS1 primer set, which queries a less-conserved 
region and targets fungi selectively.  We used a version of the ITS1F/ITS2 primer set previously 
reported to show discrimination at low levels of the fungal taxonomy [16].  
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 All primers used for amplification also contained a DNA bar code, which consisted of 12 
bases which indexed the DNA specimen studied.  Sequence reads could then be separated by bar 
code during bioinformatic analysis, allowing many amplicons to be sequenced in pools. 
Classification of amplicon sequences using BROCC (BLAST Read and OTU Consensus 
Classifier) 
  Classifying sequences from microeukaryotes presents special challenges in automated 
assignment.  1) There are large numbers of accepted synonyms for many taxonomic groups.  2) 
Databases contain an unusually high level of misclassifications.  3) Sexual and asexual forms 
(anamorphs and telomorphs) of a single fungal species can be in different taxa, even up to the 
family level.  4) Databases contain large numbers of environmental sequences with minimal or no 
classification that nevertheless are returned as hits from database searches.  For these reasons, we 
designed BROCC to classify single cell eukaryotes while respecting these limitations.  BROCC 
also facilitates interfacing with the popular QIIME pipeline[22], which was originally developed 
for use with bacterial 16S rRNA gene tags. 
 We chose to use a BLAST-based method, rather than a kmer-based classifier such as 
RDP [29], because the high level of variation between closely related ITS sequences could result 
in misplaced assignments.  Phylogenetic-based methods such as ARB [27]have difficulties with 
ITS sequences because of rapid divergence and common indels. 
 BROCC classifies amplicons using BLAST searches against large and relatively 
uncurated databases.  There are curated databases for several eukaryotic amplicons that can be 
used for phylogenetic assignment [17,20], but large curated databases do not exist for ITS1, 
which is used here.  It is widely speculated that the great majority of fungi have not been studied, 
motivating use of the broadest possible databases for human microbiome studies.  BROCC uses 
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blastn, but output from other versions of BLAST such as blastx can be substituted.  Parameters 
are user-adjustable. BROCC first filters input BLAST hits for sufficient coverage and identity to 
the query sequence. If a query sequence has too many hits that are below the preset coverage 
threshold (70% default), or BLAST did not return a hit, it is not classified, and a message is 
written to the output file. BROCC then determines the identity and taxonomic hierarchy of each 
high quality hit using a local user installed sql database and NCBI’s e-fetch tool.  
 BROCC then votes on the quality filtered BLAST hits, starting at the species level. At 
each level of the taxonomy BROCC requires the taxon with the most votes to surpass a user 
specified threshold for that level in order to accept it as a valid classification. If a sufficient 
majority is not reached, BROCC will not make a classification for that level and iterate to the 
next higher taxonomic level for another round of voting.  BROCC filters are independently 
configurable at the genus and species levels, and another filter can be assigned for the remaining 
taxonomic levels.  Here different defaults were used for ITS and 18S rRNA gene amplicons.  
Species and genus defaults for ITS rRNA gene amplicons were chosen on the basis of [30], and 
are 95.2% and 83.05%; 80% was used for higher taxa. For 18S rRNA gene amplicons, experience 
(data not shown) indicated that 99% was suitable for species attribution, 96% for genus, and 80% 
for higher levels. 
 BROCC also contains a user modifiable list of high level and partial assignments in its 
configuration file. These assignments are ignored at lower taxonomic levels where they are 
uninformative and can distort voting, but included in higher levels. For example, a sequence read 
with a kingdom level assignment only is excluded up to the kingdom level, at which point the 
vote is counted in the kingdom assignment. In cases where the proportion of high level and partial 
assignments exceeds a given threshold (default 0.70), the query sequence is unassigned and 
marked accordingly. 
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 BROCC output includes both files containing classifications with standardized taxonomy 
(domain, kingdom, phylum, class, order, family, genus, species) and a second with the complete 
NCBI taxonomy[31], which includes subtaxa, supertaxa, and unranked intermediate taxonomic 
levels. The third file contains a log of the voting record, including how many votes were cast, 
how many votes the winning taxon received, and how many generic classifications were ignored 
for each query sequence. This file also indicates those queries that were unclassified. Both 
taxonomy files are suitable for use in the QIIME pipeline (i. e. they are in the same format as the 
output classifications as the QIIME assign_taxonomy.py script).   
Testing BROCC performance on an in silico-constructed community of known membership 
 Kyle Bittinger verified performance of BROCC by testing assignments over an in silico 
generated mixed community of known membership (Figure 2-2). We selected six eukaryotic 
microbial organisms, and extracted sequences corresponding to our 18S and ITS rRNA gene 
amplicon regions. To simulate the characteristics of pyrosequencing data, we added base 
substitution errors at a rate of 1% and truncated each sequence by a length selected randomly 
from an exponential distribution, such that the average trim value was 5 bases. For each strain, 32 
different reads were generated, and then classified by BROCC.   
 For the 18S rRNA gene sequences, the majority of reads for each organism were 
classified to at least the genus level for 4/6.  One of the remaining two was classified at the family 
level, and another was classified at only the phylum level (Rhodotorula bacarum).  For 
Rhodotorula, the NCBI taxonomy jumps from phylum to genus, disrupting attribution.  For the 
ITS amplicon, 4/6 were classified to the species level and one was classified at the genus level 
(Penicillium). Dendryphion was unclassified, due to an abundance of short sequence matches in 
the database that covered less than 70% of the ITS query and thereby disrupted assignment.  We 
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conclude from this that 1) BROCC works well for attribution even in the presence of sequence 
errors and truncations, 2) the ITS amplicon yields lower level assignments than the 18S rRNA 
gene amplicon for those sequences accessible with the ITS primers used, and 3) failed 
assignments were mainly attributable to problems in the underlying database. 
 
Testing the pipeline using a collection of DNAs from microeukaryotes of clinical interest 
 In order to test the performance of our pipeline, we tested DNA extracted from clinical 
isolates of fungi and molds, as well as selected laboratory strains of model eukaryotes 
(Supplementary Table 2-1).  We also tested DNA from humans and Arabidopsis thaliana, which 
are selectively non-targeted organisms. DNA samples were amplified with our 18S and ITS 
rRNA gene primer pairs and sequenced using the 454/Roche platform.  The raw sequences 
(54,698 for 18S rRNA genes, 35,259 for ITS genes) were processed and denoised in the QIIME 
pipeline [22].  OTUs were formed with percent identity values used for species level attribution 
above.  Taxa were assigned using BROCC.  We scored a BROCC classification as correct if it 
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returned an accepted synonym, anamorph, or teleomorph from the Mycobank database [32] or the 
NCBI taxonomy database matching the known assignment (Figure 2-3A and B).   
 For the 18S rRNA gene amplicon, of the 23 classified samples tested, the major OTU 
was annotated as the correct organism at the family level or lower for 18 specimens and at the 
genus level or lower for 16 specimens (Figure 2-3A).  Taxa called correctly at the genus level or 
lower included Aspergillus, most Saccharomycetaceae yeasts (Candida and Saccharomyces), 
Penicillium, Pneumocystis, and Toxoplasma gondii.  A low number of reads were detected for 
Arabidopsis thaliana despite the effort to avoid amplifying plant DNA, and these reads were also 
correctly placed.  Taxa called correctly to the family level included Leishmania and Candida 
glabrata.  Coccidioides was called correctly at the Class level.  The human DNA sample yielded 
only low numbers of reads, and the most abundant OTU matched Saccharomycetaceae yeasts, 
consistent with the idea that only low level contaminating environmental DNA amplified from 
these samples. Plasmodium did not amplify with this primer pair, consistent with the large edit 
distance between the primer sequences and the rRNA gene target.  
 Cryptococcus neoformans classified correctly to the species level, but Cryptococcus 
laurentii initially only classified correctly to the phylum level.  Analysis showed this was due to a 
large number of database entries for closely related sequences annotated as ‘Uncultured soil 
basidiomycete’.  We thus added this term to our list in BROCC of unhelpful classifications to be 
excluded, after which C. laurentii was correctly classified to the Class level.   
 For the ITS gene amplicon, of the 23 samples tested, the major OTU was annotated as the 
correct organism at the genus level or lower for 18 specimens (Figure 2-3B).  Taxa called 
correctly included Aspergillus, Cryptococcus, Penicillium, Pneumocystis and 
Saccharomycetaceae yeasts (Candida and Saccharomyces). Human and Arabidopsis were not 
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correctly called and the major OTU corresponded to a Saccharomyces yeast, consistent with low 
level contamination. We also failed to correctly call the Apicomplexan samples (Plasmodium and 
Toxoplasma), consistent with the presence of several mismatched basepairs in the forward primer, 
and Leshmania.  Again, for most of these the numbers of reads were low and corresponded to 
abundant environmental Fungi which were probable contaminants.    
 One clinical strain was dubbed a Dematiaceous mold, which is not a taxonomic identifier.  
Analysis of the 18S rRNA gene amplicon data called it only as Ascomycota, because divergent 
annotation a lower levels obstructed deeper classification by BROCC.  However analysis of the 
ITS amplicon data called it as genus Exophalia, which fits with the clinical profile. 
 Most samples also showed additional low level OTUs, usually represented by less than 5 
sequence reads unrelated to the correct call.  In some cases these were identifiable as common 
environmental Fungi that likely contaminated either the original DNA samples or reagents used 
for DNA purification.  Extensive amplification of extraction negative controls occasionally 
yielded such OTUs (data shown below).  Other low level OTUs in Figure 2-3 were not identified 
and may be products of mispriming, chimera formation, or pyrosequencing error. 
Figure 2-3.  Analysis of DNA samples from known eukaryotes. A) 18S and B) ITS rRNA 
gene amplicons.  The sample tested is listed along the x-axis.  The y-axis shows the level of 
taxonomic placement of each OTU in each sample relative to the correct taxon indicated on 
the x-axis.  The numbers of sequence reads are shown by the size of the point.  Thus large 
circles high up on the y-axis indicated correct placement of the major taxa.  
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Comparison of DNA purification methods 
 Choice of cell lysis and DNA extraction methods influences both the DNA yield and 
proportions of taxa for bacterial 16S rRNA gene analysis [2], and the known difficulties of lysing 
yeasts suggest the issue may be even more pronounced here.  We thus compared four different 
extraction methods for preparing samples for analysis of eukaryotic rRNA gene sequences: PSP 
Spin Stool DNA Plus Kit, MoBio PowerSoil kit, FastDNA with Fungal Protocol [16], and an 
archaeal specific extraction method [21].  For some, harsher lysis steps were used than in the 
original protocols (see methods).  Eight stool samples from healthy adults were subjected to 
separate extractions with each of the four kits. The PSP kit yielded the most DNA on average for 
the same weight of starting material.  Output DNA from each method was then tested using both 
the ITS1 and 18S rRNA gene amplicons.   
 Amplification products were separated by agarose gel electrophoresis and visualized by 
staining with ethidium bromide (Supplementary Figure 2-1).  The genomic DNA from the 
FastDNA protocol produced no detectable amplification. The PSP and PowerSoil extractions 
produced similar banding patterns on ethidium bromide stained agarose gels, though the PSP 
extractions produced brighter bands overall. The archaeal extraction method produced sporadic 
bands that were generally less bright than the PSP and PowerSoil samples.  Based on these 
findings, the PSP kit seems superior.  The archaeal, PSP, and PowerSoil samples were then 
compared after deep sequencing by the 454/Roche method.  
Comparison of taxa reported with the 18S and the ITS rRNA gene amplicons for human stool 
samples 
 We acquired 54,411 sequence reads for the 18S rRNA gene amplicon and 39,827 
sequence reads for the ITS1 amplicon from the 8 stool samples (Supplementary Table 2-2).  The 
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sequence reads were clustered into OTUs and assigned to eukaryotic taxa using BROCC.  The 
relative abundance of community members was assessed by plotting OTUs ranked by abundance 
versus their within sample abundance for samples extracted with the PSP method (Figure 2-4A 
and B). The 18S rRNA gene amplicon yielded 93 OTUs and the ITS amplicon yielded 215 OTUs.  
For both the 18S and ITS rRNA gene amplicons, a few OTUs contained most reads, and this was 
more pronounced for the 18S rRNA gene amplicon data.  The majority of OTUs assigned by 
BROCC from both amplicons belonged to fungal phyla (62.4% in 18S and 90.5% in ITS1 rRNA 
gene amplicons), mainly Ascomycota (81.0% in 18S and 57.4% in ITS1 rRNA gene amplicons) 
and Basidiomycota (17.2% in 18S and 25.7% in ITS1 rRNA gene amplicons).  Recovery of plant 
and animal DNA from the 18S and ITS rRNA gene amplicons was suppressed effectively. Only 
two OTUs in the 18S rRNA gene amplicon totaling 35 reads and 5 OTUs in the ITS amplicon 
totaling 5 reads were classified as plant. No OTUs were classified as vertebrate, though in other 
experiments with these primers small numbers of host and vertebrate sequences have been 
detected (data not shown). 
 The numbers of reads returned for each OTU can be used as a surrogate for relative 
abundance, though this measure must be used with caution due to unequal amplification due to 
internal secondary structure, differential complementarity of target sequences and primers, and 
different amplicon lengths.  The proportions of sequences are shown as stacked bar graphs in 
Figure 2-5 for the PSP and PowerSoil extraction methods.  Yields from the Archaeal extraction 
were lowest of the three, and showed multiple samples with few or no reads, and so were not 
studied further.  Sequence reads were detected in 6 of 8 negative controls (Figure 2-5 B and D), in 
which DNA-free water was subjected to the purification, amplification and sequencing 
procedures, but the read numbers were typically much lower than for the stool samples 
(Supplementary Table 2-2). 
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Figure 2-4.  Rank-abundance plots for OTUs from stool samples. A) 18S and B) ITS rRNA 
gene amplicons.  The rank (relative abundance) of each OTU is shown on the x-axis, with 
the most abundant on the left.  The proportion contributed by that OTU is shown on the y-
axis. The key in the upper right shows the color code for the different human subjects 
studied. 
 For the 18S rRNA gene amplicon, 99.6% of fungal reads were assigned to Ascomycota, 
while the rest were assigned to Basidiomycota, except for a 3 read OTU assigned to 
Entomophthora.  For the ITS amplicon, 83.7% of fungal reads were assigned to Ascomycota, 
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9.79% were assigned to Basidiomycota, and 6.4% were only classified to the kingdom level. 
Twelve reads from PowerSoil extraction of subject 1006 were assigned to Mucoromycotina. 
 The 18S rRNA gene amplicon also detected two gut parasites, Blastocystis and 
Endolimax.  These were not detected using the ITS amplicon, which is specific for Fungi.  The 
DNA extraction method used affected the results--Blastocystis was detected in both the PSP and 
PowerSoil extractions from subject 2006 and Endolimax in the PSP extraction in subject 2006, 
but not in samples extracted by other methods.  It is unclear whether this divergence is due to bias 
in the extraction methods or uneven distributions of organisms in stool samples. 
 The Saccharomycetaceae proved to be the dominant lineage in the eight stool samples for 
both the 18S and ITS1 rRNA gene amplicons.  Both amplicons were dominated by 
Saccharomyces and Candida genera (Figure 2-5A and C). The majority of Saccharomycetaceae 
reads recovered with the 18S rRNA gene amplicon were classified as Saccharomyces in all 
samples.  However, for the ITS1 rRNA gene amplicon, reads were classified as a mixture of 
Candida and Saccharomyces.  Analysis of the 18S rRNA gene sequence over the window queried 
by our amplicon revealed that Saccharomyces and Candida are poorly distinguished over this 
region, which was corroborated by a multilocus phylogeny over the Saccharomycetaceae family 
[33]. 
 Aside from the typical gut inhabitants, our study yielded several examples of fungal 
rRNA genes potentially derived from food.  In subject 1006, Agaricus bisporus, the common 
button mushroom, was detected as a high count OTU using all extraction methods for the ITS1 
amplicon samples.  Claviceps purpurea, which grows on rye and other cereals and is a causative 
agent of ergot [34], was detected as a rare OTUs in subjects 1002, 1006, and 2006.  Wallemia 
sebi, often found in food[35], was detected in 1002, 1006, 1009, and 2005 for multiple extraction 
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methods. The substantial amount of Saccharomyces that appeared in all subjects, may be derived 
from bread, beer, or other leavened and fermented foodstuffs.  Distinguishing fungal sequences 
derived from food presents an ongoing challenge in gut microbiome studies.  
 
Figure 2-5.  Comparison of major eukaryotic microbes detected in human stool. Samples 
were assayed with the 18S rRNA gene amplicon, the ITS1 rRNA gene amplicon, and the 
shotgun genomic data in human stool.  Human subjects and DNA purification methods are 
as indicated on the x-axis.  Taxa are shown at the Family level or as indicated.  A)  18S 
rRNA gene amplicon used to analyze stool samples.  B)  18S rRNA gene amplicon 
contamination controls.  C)  ITS amplicon stool samples.  D)  ITS rRNA gene amplicon 
contamination controls.  The contamination controls in B) and D) consisted of DNA-free 
water passed through the full DNA purification, sequencing and analytical pipeline--6 of 8 
samples yielded pyrosequence data, though with low read numbers.   
Comparison of the performance of BROCC to other classifiers over the experimental data sets. 
 Taking advantage of these data, we next compared BROCC to two other classifiers, 
MEGAN and MARTA, which were not specifically designed for use with single cell eukaryotes.  
Supplementary Table 2-4 summarizes the differences among the programs.  For more discussion 
of the assignment problem see [36,37,38,39] and references therein. 
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 The three programs were first tested by comparing for the number of correct assignments 
for the known samples in Figure 2-3.  The number of samples with correct assignments for the 
18S rRNA gene amplicon at the Genus level or lower were 17 for BROCC, 19 for MARTA, and 
3 for MEGAN out of 20 possible.  For the ITS amplicon, the numbers were 18 for BROCC, 11 
for MARTA, and 6 for MEGAN out of 18 possible.  Thus BROCC and MARTA were 
comparable, with BROCC performing somewhat better for the ITS gene amplicon.  MEGAN was 
more conservative and made fewer low level assignments for ITS, because it was more strongly 
influenced by database errors or alignments with only high level taxonomic placements.   
 In some comparisons, MARTA yielded more low level classifications due to accepting 
single high quality matches for assignment, which can be an advantage or disadvantage 
depending on the quality of the underlying database.  MARTA classified Candida krusei as 
Pichia fermentans in the 18S rRNA gene amplicon and Coccidioides immitis as Coccidioides 
posadasii in the ITS amplicon. MARTA considered 4 database hits for C. krusei and 6 for C. 
immitis, while BROCC considered 98 for C. krusei and 27 for C. immitis.  In both cases BROCC 
made a correct genus level assignment only and not the erroneous species level assignment.  In 
four cases in the ITS amplicon assignments, MARTA failed to make an assignment due to 
interference from multiple aligning database sequences assigned as "unidentified" or 
"uncultured", which were correctly classified to low taxonomic levels by BROCC. 
 We then compared the assignments for BROCC and MARTA against the human stool 
samples, for which the composition is not known. MEGAN was not considered further due to 
inferior performance on the known samples.  We assigned each classification level a score.  
Species level assignments received value 1, genus value 2, and so on up to unclassified, which 
received value 9.  Scores were compared between BROCC and MARTA.  This showed that 
BROCC consistently yielded lower level classifications (Wilcoxon signed rank test; p=0.014 for 
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the 18S rRNA gene amplicon, and p=4.1x10
-15
 for the ITS amplicon).  Inspection of the data 
showed the numbers of unclassified OTUs generated by MARTA was largely responsible for the 
inferior score.   
 BROCC also contains functionality assisting in implementation that is lacking in the 
other packages (Supplemental Table 2-4).  BROCC can extract useful information from partial 
assignments -- for example, a database hit assigned only at the kingdom level, is not tallied during 
the process of assignment at lower ranks, but considered in the case of a kingdom assignment.  
BROCC reports the reason for excluding database hits in the output file.  BROCC also outputs 
file types that are easily integrated into the QIIME pipeline [22] for evaluation of microbial 
community structure, accelerating downstream steps in a typical analysis. 
2.5 Discussion 
 Here we present a pipeline for characterization of eukaryotic taxa in microbiome 
samples.  For many types of samples, single cell eukaryotes are a minority component, so that 
shotgun metagenomic analysis is inefficient and expensive.  Thus, despite the rapid advance of 
methods, marker gene analysis remains the method of choice for many applications.   
 We describe experiments to characterize the performance of two primer sets querying the 
eukaryotic ribosomal rRNA genes.  Data from us and others shows that interfering DNA from 
food or host cells must be considered in designing the amplification strategy.  We thus devised an 
18S rRNA gene amplicon that selectively avoids plant and animal 18S rRNA gene sequences.  
We also studied a second amplicon that targets ITS sequences from Fungi, which also minimizes 
contamination with plant and animal DNA but queries a narrower group of eukaryotes.  The ITS 
rRNA gene region studied is more diverse than the 18S rRNA gene region, allowing lower level 
phylogenetic placement of some fungal groups.  Both amplicons were effective in detecting 
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Aspergillus, Saccharomycetaceae, Penicillium, and Pneumocystis. The 18S rRNA gene amplicon 
selectively detected Leishmania and Toxoplasma.  In stool, the 18S rRNA gene amplicon but not 
ITS detected Blastocystis and Endolimax.  The ITS amplicon selectively classified Cryptococcus 
and the Dematiaceous mold.  Neither primer set detected Plasmodium. Both amplicons detected 
Saccharomycetaceae yeast as the major group in stool samples.  In unpublished work, the ITS 
amplicon has also been used to characterize bronchoalveolar lavage samples that were also typed 
in clinical culture-based assays, producing nearly identical assignments (E. Charlson, R. Collman, 
and F. D. B., unpublished data). 
 The present state of fungal taxonomy creates challenges in data analysis.  Most fungi 
have not yet been formally described by taxonomists [40], so many sequence reads will be from 
unknown groups.  Names differ for anamorphs (asexual forms) and teleomorphs (sexual 
reproductive forms) of what are apparently the same species, either of which may occur in the 
microbiome [41]. Consequently, several OTUs were classified with different names, but belonged 
to the same holomorph (pool of anamorphs and teleomorphs).  Even though they are the same 
holomorph, Candida is taxonomically placed in the family Saccharomycetaceae, but Clavispora 
is placed in the family Metschnikowiaceae. Efforts to improve databases by eliminating the dual 
naming system and creating accurate phylogenies for fungi should help in this regard [17]. 
 We demonstrated that DNA can survive passage through the GI tract of a mouse, albeit 
inefficiently, and our rRNA gene amplicon assays of human stool did detect some OTUs that 
likely came from food.  For some of the fungal groups, it is difficult to know whether they are 
true gut residents or transients from food.  Perhaps the development of detailed databases of 
eukaryotic rRNA gene sequences common in human food can assist in distinguishing true gut 
residents from transients.  
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Supplementary Information 
 
Supplementary Figure 2-1. Comparison of PCR amplification reactions for DNA purified 
from stool using different methods.  Average DNA yields were: PSP 59.6 ng/μL, PowerSoil 
30.4 ng/μL, FastDNA extraction 15.8 ng/ μL, and the Archaeal method 12.7 ng/μL.  PCR 
products were separated on an 0.8% agarose gel and stained with ethidium bromide.  Top: 
amplification products generated using the 18S primer pair.  Bottom: amplification 
products generated using the ITS1F-ITS2 primer pair.   
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Supplementary Figure 2-2. Analysis of DNA samples from known eukaryotes using 
BROCC, MARTA, and MEGAN. (a) 18S and (b) ITS rRNA gene amplicons classified by all 
three classifiers. The sample tested is listed along the x-axis. Individual OTUs in each 
sample are shown by the points, which are sized in proportion to their read counts. A point 
is colored by the program and configuration used to classify that point. These data were 
classified by BROCC using default settings, MARTA using default settings, MARTA using 
a BLAST word size and voting thresholds to match the BROCC default settings, MEGAN 
using default settings and the same blastn output used by BROCC, and MEGAN using an 
abbreviated blastn output with a maximum of five hits per query sequence. The lowest level 
of correct classification for each OTU is listed on the y-axis.  
 
Supplementary Figure 2-3. Pseudocode of the BROCC program. 
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Supplementary Figure 2-4. Flow chart of BROCC implementation. 
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Primer Amplicon Sequence 
 
 
18S_0067a_deg 18S AAGCCATGCATGYCTAAGTATMA 
 
 
NSR 399 18S TCTCAGGCTCCYTCTCCGG 
 
 
ITS1F ITS1 CTTGGTCATTTAGAGGAAGTAA 
 
 
ITS2 ITS1 GCTGCGTTCTTCATCGATGC 
 
     
 
Supplementary Table 2-3. Oligonucleotides used in this chapter. 
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CHAPTER 3: Protocol to Characterize Archaea in the Microbiome 
through Sequencing 
3.1 Abstract 
 Prior to this work, efficient methods to characterize archaeal communities in the gut 
microbiome by deep sequencing were not available. Here we surveyed primers previously used 
for archaeal community characterization in environmental samples to identify primers that both 
exclude host DNA and detect archaea. Additionally we refined wet side DNA extraction methods 
and thermocycler conditions to improve detection with successfully validated primers. 
Ultimately, we present a working protocol for characterizing the archaeal community 
composition in the gut microbiome. 
3.2 Introduction 
The archaea consist of a diverse group of prokaryotes that are phylogenetically closer to 
eukaryotes than bacteria[1]. The archaea inhabit most settings on Earth including environments 
with extreme heat[2], cold[3], salinity[4], and high[5] and low[6] pH, in addition to more 
temperate locales[7]. The archaeal ability to live in extreme environments and phylogenetic 
distinctiveness has lead to the evolution of characteristic cell wall, cell membrane, and surface 
structures[8], along with metabolic capabilities that are unique to the archaea, such as 
methanogenesis[9] and synthesis of distinctive lipids[10].   
 Due to the archaea’s genetic and biochemical distinctiveness, much interest has been 
generated around detecting and characterizing archaea in the human microbiome, since archaea 
would be potentially able to fill a unique niche in the microbiome community[11] [12]. Prior to 
this dissertation, Methanobrevibacter smithii was acknowledged as the dominant commensal 
archaeon in the gut microbiome[13,14] and present in most individuals[15]. Methanospheara 
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stadtmanae has also been documented to occur in some individuals [16]. Here we develop 
methods to characterize the archaeal community through sequencing. 
3.3 Materials and Methods 
Samples and DNA Extraction 
In the preliminary studies the initial macaque stool samples were extracted with the 
Qiagen Stool kit as per the manufacturer’s instructions and were described in detail previously 
[17].  4 of the samples (AM40, AV86, MIT4, and C2T64) came from SIV positive macaques. 
The remaining 4 samples (DE20, C2T3, C2T10, and C4T1) came from uninfected macaques. All 
the murine samples came from healthy mice. DNA from these samples was extracted with the 
same method used for the macaques. 4 of the samples (11F, 12B, 13B, and 15D) were described 
previously [18], and 3 (IKK2, IKK4, and IKK5) were produced for another unpublished study.  
The human samples used for later study were derived from self reported healthy adults 
and extracted with the PSP kit modified for difficult to lyse cell wall. The stool samples[19,20] 
and their extraction[21] were described previously.   
Primer Selection and Modification 
 We formed the initial set of tested primers through a search of the literature 
[22,23,24,25]. The 958af primer was modified after a visual inspection of alignment to several 
Solfulobus and related 16S sequences from the GenBank[26] database and the UCSC Genome 
Browser[27]. The 17th base pair made degenerate from G to K (G or T). 
Amplification Protocol 
 Initial test amplifications were preformed with the GreenTaq system.  Reactions 
contained 10μL genomic DNA diluted to 5 ng/μL, 2 μL of each primers diluted to 20 pmol/ μL, 
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4.3 μL Greentaq Mix,  5.7 μL water, .5 μL BSA (10mg/mL), and 2.5 μL Triton (1%). We used 
the following thermocycles protocol: denaturing at 95°C for 5 minutes, 25 cycles of amplification 
with 30 seconds for denaturing at 95°C, 30 seconds of annealing at 50°C or 55°C, and 72°C for 
90 seconds. At the end of the program, there was an 8 minute extension at 72°C.  
  Later amplifications used the Accuprime system according the manufacturer’s 
instructions. Thermocycler conditions were as follows:  initial denaturing for 5 minutes at 95°C, 
then 47 cycles of amplification with 30 seconds of denaturing at 95, 30 seconds of annealing at 
variable temperatures, and 90 seconds of extension at 72°C. The annealing temperature started at 
67°C and decreased by 1°C each cycle until it reached 55°C, where it remained for 10 cycles. 
Next, it decreased to 53°C for 5 cycles, then decreased to 50°C for 20 more cycles. Afterwards 
there was an 8 minute extension at 72°C.  
Sequencing and Bioinformatics 
 Amplified DNA was cloned with the Invitrogen TOPO4 and TOPOXL cloning kits 
according the manufacturer’s instructions.  Samples were sequenced on an ABI 3730 DNA 
analyzer.  Sequences were classified the web based RDP classifier tool [28]. Classifications were 
checked with NCBI’s BLAST and the RDP SeqMatch tool. 
3.4 Results 
Primer Selection 
 Several studies have used the archaeal 16S rRNA gene to characterize and analyze 
archaeal communities in environmental samples from seawater[29,30], soil[31,32], and 
others[33], prior to this work.  Through a literature search, we collected 6 noted archaeal specific 
16S rRNA primers (Table 3-1) [22,23,24] and paired each one with the universal 1378ar reverse 
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primer[25], which amplifies both archaea and eukaryotes. We used this scheme to test the 
specificity of individual forward primers.   
Name Sequence 5'-3' Source 
4aF TCCGGTTGATCCTGCCRG Grobowski 2005 
398aF CCRGGCCCTACGGGG Baker 2003 
571aF GCYTAAAGWRDCCGTAGC Baker 2003 
1040aF GAGAGGWGGTGCATGGCC Baker 2003 
958aF AATTGGAKTCAACGCCGGR Collins 2005 
1204aF AGGTMBGYATGCCCCKAA Baker 2003 
1378aR TGTGTGCAAGGAGCAGGGAC Lepp 2004 
Table 3-1. Primer sequences used in this chapter.  
 Primers pairs were queried against a set of extracted stool samples from healthy mice and 
healthy and SIV infected macaques extracted with the Qiagen Stool Kit.  Samples were initially 
amplified using 25 PCR cycles at annealing temperatures of 50°C and 55°C, based on a 
previously described procedure for amplifying 16S[17]. Amplifications with annealing 
temperatures at 50°C generally produced brighter bands than the 55°C amplification but consisted 
of nonspecific amplification, so amplifications at 55°C were considered. 
 In initial tests, two of the forward primers, 571af and 1204af, produced no bands and 
were not considered. Two more forward primers, 398af and 1040af, produced visible bands, but 
bands were determined to be off target eukaryotic host sequences upon Sanger sequencing.  The 
remaining forward primers, 4af and 958af, produced bands in a limited number of samples (Fig 3-
1), which were verified with Sanger sequencing. All reads produced from macaque samples were 
classified as Methanobrevibacter with the RDP classifier. All but one read produced from the 
murine samples were classified as Methanobrevibacter. The remaining murine derived sequence 
was classified with 79% confidence as belonging to the extremophile genus Thermogymnomonas, 
which prior to this work has been observed in hot springs[34].  The murine samples only 
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produced visible amplification with the 4af forward primer, and the macaque samples only 
produced visible amplification with the 958af forward primer. The reason for this is unclear, since 
k-nearest neighbor analysis with the RDP classifier tool made taxonomic assignments for reads 
from both the macaque and mouse samples to archaeal species that have homology to both the 4af 
and 958af primers.   
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Assay Refinement 
 Upon assessment of sequencing results, we selected the 958aF/1378aR for further 
development, due its small amplicon size (~450 base pairs), which was suitable for adaption for 
454 sequencing.  Through endpoint PCR testing of genomic DNA derived from pure culture 
Sulfolobus solfataricus, we observed that the 958aF/1378aR primer pair does not produce visible 
amplification on an ethidium bromide stained gel. Bioinformatic analysis of database sequences 
revealed that this effect was caused by a point mutation 2 base pairs from the 3’ end of the 958aF 
primer.  This mutation occurs in species spanning the entire Sulfolobales order. Because we were 
unsure if any members Sulfolobales reside in the gut microbiome, we decided to modify the 
958aF primer by making the 17th base pair degenerate from G to K (G or T). This new primer 
was renamed 958aF-deg. 
 Despite amplifying target archaeon sequences with the previously described methods, 
some of the sequenced data from the 958aF/1378aR primer pair resulted from nonspecific 
amplification. We implemented a complex touchdown thermocycler protocol, which reduced the 
presence of off target sequences (see methods). Also, after seeing an increase in amplification 
performance in fungal detection assays after surveying different extraction methods[21], we used 
to the PSP extraction method modified for difficult-to-lyse cells (see methods) and saw a 
corresponding increase in performance in endpoint PCR, which was unsurprising because 
archaeal cell walls have been documented as relatively hard to lyse [15]. Also we changed our 
PCR cocktail to use Accuprime taq, which has been documented to perform well with difficult-
to-amplify samples (unpublished observations), and saw a dramatic increase in amplification in 
endpoint PCR. With this improved extraction and amplification procedure, we were able to detect 
archaea in a higher proportion of human samples.  Limited sequencing was preformed with the 
Sanger method on 8 human samples extracted with the PSP kit (Fig 3-2). All reads from human 
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samples were attributed to Methanobrevibacter. Off target amplification of the host genome was 
not observed for these samples. 
         
Disease 
Status Healthy 
Species Human  
Subject  1002 1003 1006 1009 1011 2005 2006 2011 
958/1378                 
         
 
  
Confirmed by 
sequencing  
    
 
  
Band of correct size, but 
not sequenced  
    
         Figure 3-2 Amplification of human stool samples over the 958aF/1378aR primer pair. All 
samples were obtained from healthy adults and extracted with the PSP kit with bead 
beating. Designation of the individual from which the stool sample was obtained is 
indicated by the second row.  Amplification results are indicated by the colors of chart 
boxes. Amplifications were preformed with Accuprime and a double touchdown 47 
cycle thermocycler program. 
         
3.5 Discussion 
Prior to this work, M. smithii had been documented to live in the human gut, but genomic 
assays for detection of archaea more broadly in the human microbiome were not developed. This 
work demonstrates the wide spread existence of archaea in the gut and lays a foundation for 
characterization of the archaeal microbiome community. While Methanobrevibactor was the 
predominant species detected through sequencing, Thermogymnomonas was detected as well, 
suggesting multiple archaeal species inhabit the gut. The method described here was further 
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developed for 454 sequencing by Christian Hoffmann and was successfully applied to a large set 
of human stool samples, where several divergent lineages were detected, including 
Methanobrevibactor, Nitrosospheara, Methanospheara, Thermoplasmata, and 
Thermogymnomonas.  While the archaea compose a minority component of the microbiome, 
further studies are needed to determine how their unique metabolic capabilities change 
community function and dynamics.  
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CHAPTER 4: Perturbation of Fungi and Bacteria through Antibiotics 
in the Murine Gut 
The contents of this chapter have been submitted for publication in: 
Dollive S, Chen YY, Grunberg S, Bittinger K, Vandiver L, Cuff C, Lewis JD, Wu GD, 
Bushman FD. (2013).  Fungi of the murine gut: episodic variation and proliferation 
during antibiotic treatment. 
4.1 Abstract 
Antibiotic use in humans has been associated with outgrowth of fungi.  Here we 
investigated the gut microbiome over 76 days of antibiotic treatment and recovery using a 
controlled mouse model.  Mouse stool was studied a surrogate for the microbiota of the lower 
gastrointestinal tract.  The abundance of fungi and bacteria was measured using quantitative PCR, 
and the proportional composition of the communities quantified using 454/Roche pyrosequencing 
of rRNA gene tags.  Bacteria dropped >3 orders of magnitude after initiating treatment, so that 
the predominant 16S sequences detectable during treatment were transients derived from food.  
Upon cessation of treatment, bacteria mostly returned to their previous numbers and types after 8 
weeks, though communities remained detectably different from untreated controls.  Fungal 
communities varied substantially over time, even in the untreated controls.  Separate cages within 
the same treatment group showed radical differences, but mice within a cage generally behaved 
similarly.  Fungi increased 40-fold in abundance upon antibiotic treatment but declined back to 
their original abundance after cessation of treatment.  At the last time point, Candida remained 
more abundant than prior to treatment.  These data show that 1) gut fungal populations change 
radically during normal mouse husbandry, 2) fungi grow out in the gut upon suppression of 
bacterial communities with antibiotics, and 3) perturbations due to antibiotics persist long term in 
both the fungal and bacterial microbiota. 
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4.2 Introduction 
The gut microbiome is generally stable but can be changed through exterior perturbation. 
Perturbation can be introduced through changes in diet [1], changes in the immune system [2], 
presence of a pathogen [3], and use of probiotics [4] or antibiotics [5], and others factors. 
Antibiotic use is perhaps the most common and dramatic source of change in the microbiome 
community and is a subject of clinical interest.  
The effects of antibiotic use on the human microbiome can be challenging to clarify 
fully--confounding factors include complications of the underlying diseases states and 
concomitant use of additional forms of therapy[6].  Despite these difficulties, outgrowth of fungi 
has been repeatedly linked to antibiotic treatment at body sites including the gut[7,8], vagina[9], 
mouth[10], skin[11] and others [12,13]. Fungal infection associated with antibiotic use is of 
particular concern in immunocompromised states such as HIV/AIDS[14,15,16], some 
cancers[13,17,18], and transplantation[19,20,21,22] [23].  Many of these conditions necessitate 
the use of corticosteroids, which further predisposes the host to fungal infection[24]. Invasive 
fungal infections have been increasing in recent decades[6,17], and the rise of azole-resistant 
species of Candida[12,25], Aspergillus[26,27], and Cryptococcus[14,28] brings further urgency 
to understanding the interaction between commensal fungi and bacteria under antibiotic 
treatment.  
Rodent models have been used to study the effects of antibiotics on the mammalian gut, 
using culture based[29,30], metagenomic[31], and immunologic[31,32] methods. Antibiotic 
treatment can predispose the host to infection by pathogens[33,34] and alter microbial 
communities long term[34]. Induced exposure to Candida albicans shapes the bacterial 
composition of the murine gut during antibiotic recovery[30] and can cause gastritis[35], while 
Candida tropicalis has been associated with increased severity in ulcerative colitis[36]. 
78 
 
Phenotypic effects have been found even after treatment with subclinical doses of antibiotics [37]. 
In studies of the role of the vertebrate microbiome in mice, antibiotic treatment is often used to 
suppress the host bacteria, but the effect of this intervention on fungi is not commonly considered 
[33,38,39,40].   
 Here we characterize the bacterial and fungal microbiota of mice during antibiotic 
treatment and subsequent recovery after cessation.  We analyzed abundance using quantitative 
PCR (henceforth “QPCR”), and analyzed the types present using 454/Roche pyrosequencing of 
rRNA gene tags. We found that fungi indeed grew out upon antibiotic treatment. After cessation 
of antibiotic treatment, fungal and bacterial communities approached their pre-antibiotic states, 
but increased abundance of Candida persisted in the gut at the last time point studied eight weeks 
later. To our surprise, we also found that the fungal communities changed radically over time in 
both control and treated mice.  For each condition, specific fungi colonized multiple mice in the 
same cage, then gave way to subsequent fungal colonists over time, and different patterns were 
seen in different cages. 
4.3 Material and Methods 
Ethics Statement 
The Institutional Review Board of the University of Pennsylvania approved all IACUC protocols 
(protocol #803408).  The animal care facility is operated by the University Laboratory Animal 
Resources, which is fully accredited by the American Association for Accreditation of Laboratory 
Animal Care. Laboratory animals are maintained in accordance with the applicable portions of 
the Animal Welfare Act and their guidelines prescribed in the DHHS publication, “Guide for the 
Care and Use of Laboratory Animals”. Mice are euthanized using C02 inhalation.  Methods for 
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euthanasia are consistent with the recommendations of the Panel on Euthanasia of the American 
Veterinary Medical Association. 
Mouse Husbandry 
Thirty C57B6 eight week old female mice were purchased from Jackson Laboratory and placed 
on a standardized diet for two weeks prior to the study to stabilize their flora. Mice were housed 
by treatment group with five mice per cage. Mice treated with antibiotics received ampicillin, 
neomycin, vancomycin, and metronidazole in water. Water was spiked with aspartame in both the 
treated groups and controls. Mice were fed AIN-76A Rodent Diet from Research Diet (D10001) 
for the course of the study, which includes 15% casein lactic. 
DNA Extraction 
DNA was extracted from 1-2 mouse pellets per mouse per time point. Samples were 
homogenized for 80 seconds on a Mini-BeadBeater-16 (BioSpec) in Lysing Matrix E tubes (MP 
Biomedical). Samples were then incubated at 95°C for 15 minutes and then cooled on ice for 60 
seconds. Then samples were extracted with the PSP DNA extraction kit and using a protocol 
described previously[41].  Sequences of oligonucleotides used in this study are presented in 
Supplementary Table 4-1. 
DNA Sequencing and QPCR 
Extracted DNA was quantified with the Picogreen system.  Typical volumes produced, used in 
the calculations in Supplementary Table 4-2, were 250 microliters. DNA was amplified using 
primers annealing to the V1V2 region of the 16S bacterial gene or the ITS1 fungal rRNA gene 
spacer, and amplified with AccuPrime taq with Buffer 2 (Invitrogen). Thermocycler protocols for 
16S[42] and ITS and 18S[41] amplicons were described previously. PCR amplicons were 
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purified with Agencourt AMPure XP beads. Sequencing was performed on a 454 Junior using 
Titanium chemistry.  For both 16S and ITS amplicons, DNA free water was subjected to the same 
purification procedure and analyzed by 454/Roche pyrosequencing (Supplementary Figure 4-6).  
A subset of samples showed recoverable sequences, but stool samples showed distinct 
community composition, so conclude that environmental contamination made a minimal 
contribution to the samples analyzed. 
16S qPCR was performed using the Taqman method as described previously[31]. 18S 
qPCR was performed with the Applied Biosystems SYBRGreen Fast chemistry. Ten μL 
SYBRGreen FAST 2X master mix, 1 μL of each primer diluted to 20 pM, and 8 μL DNA were 
added to each reaction. Thermocycling was performed as follows: samples were initially 
denatured once for 2 minutes at 50°C then 10 minutes at 95°C. Then samples were cycled 40 
times with a dissociation step at 95°C for 15 seconds and an annealing and extension step at 60°C 
for 1 minute. Primer sequences for these assays can be found in Supplementary Table 4-1.  All 
DNA sequences generated in this study have been submitted to the Sequence Read Archive. 
Bioinformatic Analysis 
Bioinformatic analysis was performed with the QIIME software package[43] using default 
parameters except where indicated, and using R. Fungal reads were queried against the nt 
database using NCBI’s blastn tool and then classified with the BROCC classifier[41]. 
 Eukaryotic PCoA analysis was performed using taxonomic relationship corresponding to the 
NCBI Taxonomy[44]. Because de novo tree construction using the ITS1 region is not feasible 
due to length variation inherent in the ITS gene[41,45,46,47], we chose to asses Unifrac distances 
between eukaryotic communities using the NCBI Taxonomy to generate taxonomic trees. To 
transform the taxonomy into a phylogenetic tree, all edges between taxa were assigned equal 
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weight. Classifications were curated manually for parsimony. While the fungal taxonomy is 
imperfect and in a state flux[48,49,50,51], we note that in practice the Unifrac metric is relatively 
robust to the method used in creating phylogenetic trees[52].   Statistical significance for 
treatment groups was determined using the nonparametric Mann-Whitney test in R. Permanova 
tests and Procrustes analysis were performed in QIIME.  
4.4 Results 
Longitudinal analysis of the murine gut during antibiotic treatment 
To assess the relationship between bacterial and fungal lineages during antibiotic 
treatment, an antibiotic cocktail containing vancomycin, ampicillin, neomycin, and metronidazole 
was given to twenty C57B6 mice in water. After 2 weeks, antibiotic treatment was stopped for ten 
of the mice. These mice did not receive any antibiotics during the remaining nine weeks of the 
study (“AbxShortTerm” mice). The remaining ten mice under antibiotic treatment continued to 
receive antibiotics for the duration of the study (“AbxContinuous” mice). In parallel, ten control 
mice received no antibiotics over the course of the study (“Control” mice).  Fecal samples were 
collected over one week prior to initiating the study, then at the indicated time points during the 
study (Figure 4-1).  Mouse husbandry and sample collection was performed by Ying-Yu Chen. 
DNA was purified from stool pellets using a procedure that included bead beating and a high 
temperature incubation to facilitate lysis of fungal cells[42] by Stephanie Grunberg and Serena 
Dollive. 
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Figure 4-1.    Experimental Diagram.  The time line for the 76 days of sample collection is 
shown along the top, and the periods of antibiotic treatment are shown at the bottom.  
Antibiotic treatment was initiated at time zero. 
 
Analysis of the numbers of bacterial 16S and eukaryotic 18S gene copies present after antibiotic 
treatment  
We first investigated the changes in abundance of bacteria and fungi, using stool 
specimens as a proxy for the lower intestinal microbiome.  To assess changes in abundance, we 
first quantified the abundance of bacterial and fungal genomes in the samples per ng of DNA 
using quantitative PCR.  For bacteria, a QPCR assay was used that detected the bacterial 16S 
rRNA gene, and for fungi, an assay was used detecting the 18S rRNA gene.  The primers for the 
fungal assay were designed to suppress amplification of metazoan DNA originating from the host 
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or food materials [53].  The specificity was confirmed by pyrosequencing products of 
amplification with these primers (described below and Supplementary Figure 4-1). 
 At the start of the study, fecal pellets contained 5X10
5
 to 10
6
 copies of bacterial 16S 
rRNA genes per ng DNA (Figure 4-2).  After initiation of antibiotic treatment, this fell as low as 
100 copies per ng DNA, or a drop of >3 orders of magnitude.  Upon cessation of antibiotic 
treatment the community recovered to its former high numbers.  Thus we conclude that the 
antibiotic treatment was highly effective at reducing the numbers of bacteria present in gut, as has 
been seen in many studies (e. g. [34] [54] [55]), and that the community was sufficiently resilient 
to return to its former size after cessation of treatment. 
 
Figure 4-2.    Longitudinal analysis of 16S rRNA gene copies per ng of stool DNA. The 
groups of mice tested are shown by the color code (key at right).  Error bars indicate 
standard error. 
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 Prior to initiation of antibiotic treatment, 1-3X10
5
 18S rRNA gene copies were detected 
per ng DNA (Figure 4-3). Upon initiation of antibiotic treatment the number climbed two orders 
of magnitude, ranging between 3-6X10
8
 copies per ng DNA.  Upon cessation of antibiotic 
treatment, the numbers dropped back to roughly their former levels, thus displaying a favoring of 
smaller community size in the absence of antibiotic pressure.   
The abundance of fungi in the Control group showed an unexpected increase at day 22.  
Further analysis showed that the increase was in only one of the two cages housing the control 
animals, and correlated with the appearance of a new fungal lineage at high levels in all animals 
in that cage (described below).   
 
Figure 4-3.  Longitudinal analysis of 18S rRNA gene copies per ng of stool DNA. The 
groups of mice tested are shown by the color code (key at right).  Error bars indicate 
standard error.  The amplicon used was designed to suppress amplification of DNA from 
mouse or food materials. 
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Additional information is required to relate these numbers of rRNA gene copies to the 
numbers of organisms present.  This issue is addressed in the next section. 
Assessing the absolute abundance of bacteria and fungi 
 Several corrections are required to link the QPCR data to the total number of organisms 
per stool pellet.  One consideration is that bacterial [56,57] and fungal [58,59] genomes typically 
contain multiple rRNA gene copies.  From published data on complete genome sequences, we 
estimated the mean number of 16S rRNA gene copies per bacteria at 5 [56], and 18S copies per 
fungal genome at 100 [59], though the number for fungi is tentative due to the difficulty of 
accurately sequencing tandem direct repeats and variability in copy number. 
Another concern in assessing possible fungal outgrowth during antibiotic treatment is that 
the total number of microbes in pellets, and thus total DNA, may go down with treatment, so that 
fungi could falsely appear to proliferate only because total DNA content went down as bacterial 
numbers fell.  Thus we sought to correct the above assays, which were normalized to weight of 
DNA, to better reflect the counts of individual organisms by putting the final analysis on a per 
pellet basis.  Values for inferred microbial genomes are shown in Supplementary Table 4-2, and a 
few ratios of interest are presented in Supplementary Table 4-3. Average pellet weights were 
16.08 mg (SD=3.329) in the presence of antibiotic (n=20) and 18.64 (SD=2.685) in the control 
mice (n=19).  Thus the difference in mean weight was small (14%), so we treated starting weights 
as equal below, though the difference did achieve significance (p=0.0129, Mann-Whitney U test).   
DNA yields differed substantially (Supplementary Table 4-2).  Quantification of yields 
after 15 or 76 days of antibiotic treatment showed drops of 4.7 and 5.7 fold (Supplementary Table 
4-3).  Thus the analysis of the numbers of microbial genomes needs to take into account the drop 
in total DNA.  After withdrawal of antibiotic treatment (AbxShortTerm, Day 76), the total DNA 
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yield returned to within a factor of two of the starting value.  Evidently bacterial DNA is the 
predominant source of DNA in mouse pellets, and the community mostly returned to its former 
size after cessation of antibiotic treatment. 
Taking these factors into account, we find that in the absence of antibiotic treatment, a 
typical stool pellet contained ~10
7
 bacteria, and this dropped to ~10
2
 bacteria after 15 days of 
antibiotic treatment (Figure 4-4).  Fungal genomes were much less abundant initially, only in the 
range of 6X10
3
 per pellet.  After 15 days of treatment with antibiotics, the numbers increased to 
2X10
5
, or an increase of ~30 fold.  Fungal genome numbers remained high for the period of 
antibiotic treatment.  Eight weeks after cessation of antibiotic treatment, counts in the 
ABXShortTerm groups returned to pretreatment level. Thus changes in fungal cell abundance 
were substantial, though less than suggested by the analysis in Figure 4-3, which was normalized 
to the total weight of DNA, because total DNA went down with antibiotic treatment.  
Microscopic inspection of stool specimens also suggested an increase in numbers of large cells, 
consistent with an increase in absolute fungal numbers (data not shown).  
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Figure 4-4. Diagrams of estimated A) Bacterial and B) Fungal genomes per mouse pellet. 
 
Analysis of bacterial lineages using 454/Roche deep sequencing 
To probe microbial dynamics under antibiotic therapy, we analyzed the longitudinal 
DNA samples using 454/Roche pyrosequencing. DNA was purified from stool from 13 time 
points (Figure 4-1).  Bacterial sequences were amplified using primers matching the 16S rRNA 
gene V1V2 region [42,60].  Sequencing yielded 239,867 reads, which were condensed into OTUs 
at 97% similarity and taxonomy assigned using the RDP classifier[61].   
Prior to antibiotic treatment, communities were dominated by the Firmicute lineage 
Lachnospiraceae and the Bacteriodetes lineage Bacteroidales, along with a substantial number of 
less abundant lineages (Figure 4-5; Supplementary Figure 4-2 A-I presents time points with each 
mouse shown individually). After one day of antibiotic treatment, the previously dominant 
lineages decreased sharply in abundance, and Lactococcus became the dominant community 
member.  At later times under antibiotic treatment Lactococcus was the predominant or sole 
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lineage detectable. Five aliquots of sterile mouse chow were analyzed by amplification with the 
V1V2 primers and 454/Roche pyrosequencing, revealing that Lactococcus 16S rRNA genes were 
the predominant phylotype in chow (Supplementary Figure 4-3).  We thus conclude that 
Lactococcus DNA is present in sterile mouse food, and that the antibiotic treatment eliminated 
the great majority of live bacteria, i. e. the 10
2
 bacteria detected per pellet in Supplementary Table 
4-2 represents an upper bound. 
After antibiotic treatment was stopped for the ABXShortTerm group, major groups that 
were predominant before antibiotic treatment returned to their former levels, but at different rates. 
An OTU classified as Lachnospiraceae and several OTUs classified as Clostridium returned 
within one week. Several other clades, including Ruminococcaceae and other Firmicutes 
increased in proportion by two weeks after cessation of treatment. Bacteroidales did not fully 
return until the end of the experiment at eight weeks. Enteroccocus, Escherichia, and 
Paenibacillus, which were not dominant members of the communities in the Control or antibiotic 
treated groups, had elevated proportions over the recovery period but decreased in relative 
abundance after eight weeks off antibiotics. 
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 Changes in the types of bacterial lineages were paralleled by changes in the species 
richness (Figure 4-6). Prior to antibiotic treatment, 54.6 (SD=6.9) phylotypes were detected after 
data from each mouse was normalized to 200 reads.  After 2 days of antibiotic treatment, this fell 
to 7 (SD=2.0) and persisted for the remainder of the antibiotic treatment.  Upon cessation of 
antibiotic treatment, the community slowly returned to its former richness reaching 49.4 (SD=5.6) 
lineages over 61 days, still less than the corresponding Control group which averaged 57.2 
(SD=17) lineages on the same day (p=0.02 Mann-Whitney U). 
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Figure 4-6.  Abundance analysis of observed bacterial lineages.  Each sequence set for each 
animal was rarefied to 200 sequences per sample 10 times, and the number of different 
OTUs assessed. Means are indicated by points, error bars indicate the range observed.  The 
groups studied are indicated by the key at the right. 
Analysis of microeukaryotes using 454/Roche deep sequencing 
 To characterize microeukaryotes, we sequenced selected samples using 18S and ITS 
amplicons. 18S sequences were prepared by Lee Vandivier, and ITS sequences were prepared by 
Serena Dollive. To compare samples from the different treatment groups, 134,677 ITS sequences 
and 26,355 18S sequences were generated, OTUs were formed, and taxonomic attribution was 
preformed with BROCC [41].   The 18S amplicon is more universal than the ITS amplicon [41], 
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while the ITS amplicon provides greater resolution for some fungal lineages [48], so both were 
used [53].  To check that the two amplicons were yielding consistent information, we compared 
sequence samples from 15 mice amplified using both amplicons. Sequence samples were 
characterized by generating pairwise UniFrac distances, then the distance matrices for each were 
compared using Procrustes analysis.  This showed high correlation between the two (p<0.0001, 
no better fits after 10
4
 permutations) and compositional comparison also showed similar profiles 
(Supplementary Figure 4-1).     
 The longitudinal behavior of fungal communities was explored in detail using the ITS 
amplicon, which revealed strong effects of both antibiotic treatment and housing history of the 
animals (Figure 4-7; the full set of time points, with each animal shown individually is in 
Supplementary Figure 4 A-I).  In the control animals (five mice in each of two cages), although 
the composition of the bacterial community remained relatively stable, the fungal community 
changed dramatically.  For four samples taken over the first eight days, most of the ten mice in 
the two cages showed colonization by diverse fungal lineages, and no lineage predominated.  By 
day 15, however, the situation had changed radically, with both cages dominated by a phylotype 
annotated as Wickerhamomyces.  This changed by day 22, with cage 1 dominated by 
Debaryomyces, and the second cage showing more diverse colonization, where Debaryomyces 
was present but not predominant.  The outgrowth of Debaryomyces in cage 1 correlated with the 
increase in abundance of total DNA in the 18S QPCR analysis in the control animals at day 22 
(Figure 4-3), which also occurred only in cage 1.  By day 76 the controls had changed again.  At 
this time both cages were dominated by Eurotiales, though the abundance was greater in cage 1 
than cage 2.  These findings document radical changes in murine gut fungi 1) in a single mouse 
facility 2) for mice on a homogeneous diet, 3) in the absence of any intervention, and 4) differing 
between cages. 
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For the antibiotic treated animals, the communities were diverse prior to initiation of 
treatment, then under treatment showed cage-specific patterns of divergence.  By day 2, 
Clavispora and Cyberlindnera were predominant in both cages in the ABXContinuous group and 
cage 1 in the ABXShortTerm group.  In cage 2 in the short term group the mice were more 
heterogenous, with Candida, Cyberlindnera, and Pichia dominating in different mice.  By day 6 
this had changed, with Cyberlinderna dominating in three cages (both ABXContinuous and 
ABXShortTerm cage 1), and Candida dominating in all mice in ABXShortTerm cage 2.  This 
pattern persisted at day 15, but by day 22 one ABXContinuous cage was dominated by Candida, 
and by day 76 Candida was the only fungus detectable in both ABXContinuous cages.  For the 
ABXShortTerm mice, Sporopachydermis dominated in cage 1 and Candida in cage 2 on day 22, 
then the fungal populations returned to a more diverse mixture by day 76, but Candida was 
relatively abundant in most of the short term treated mice at the last time point studied.  Thus 
these data emphasize the heterogeneity of the community responses in individual cages, but also 
the robust persistence of the Candida community.  A few samples were also analyzed with the 
18S rRNA gene amplicon and generally yielded similar results (Supplementary Figure 4-1).  An 
analysis of mouse chow DNA using the ITS amplicon showed no obvious relationship to the 
major lineages detected in pellets (Supplementary Figure 4-3B). 
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Figure 4-7.  Longitudinal analysis of fungal lineages inferred from ITS rRNA gene 
sequencing. Fungal lineages detected are summarized in heat map format.  Data for four 
days are shown (days 1, 15, 22, and 76).  Each column indicates a single mouse.  The groups 
tested are indicated at the top of the columns.  The ten mice in each of the three treatment 
groups were each housed in two cages of five each.  The distribution of mice in cages is 
indicated at the bottom of the columns. The day of treatment is indicated at the top. The 
color code to the right indicates the proportions.  
Initially an average of 30.7 (SD=9.9) phylotypes were detected in the ITS data per animal 
(Figure 4-8), but these numbers fell to 5.2 (SD=2.9) per animal during antibiotic treatment as the 
Candida overgrew the community.  Upon cessation of antibiotic treatment the number of 
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phylotypes returned to their former levels (31.1, SD=8.0).  Thus the fungal community returned 
to its original richness (p=0.673, Mann-Whintey U), but despite this, the contribution of Candida 
was higher than before treatment.  
 
Figure 4-8.  Abundance analysis of observed fungal lineages.  Each sequence set was 
rarefied to 200 sequences per sample, and the number of different OTUs assessed.  Means 
are indicated by points, error bars indicate the range observed.  The groups studied are 
indicated by the key at the right. 
Community comparisons using Unifrac 
To compare community structures over the course of antibiotic treatment, the 454 data 
for the 16S and ITS tags were analyzed using weighted[62] and unweighted[63] Unifrac 
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(Supplementary Figure 4-5). We tested for differenced in community composition between the 
control group and the treatment groups at each time point by comparing distances within the 
control group to distances between control and treatment groups. Significance was determined 
using the Mann-Whitney test.  
The ABXShortTerm and ABXContinuous groups were not significantly different from 
the Control group before antibiotic treatment for either the bacterial or fungal communities 
(Supplementary Figure 4-5). After one day of treatment, both groups were significantly different 
from the Control in both weighted and unweighted Unifrac and remained distinct throughout the 
antibiotic treatment (Supplementary Figure 4-5).  One week after the ShortTermABX group 
stopped receiving antibiotics, both the bacterial and fungal communities remained significantly 
different from the other two (Supplementary Figure 4-5). On day 76, 61 days after antibiotic 
cessation, differences between the bacterial communities were slight but still achieved 
significance in the weighted and unweighted analysis, and some but not all comparisons were 
significant for the ITS analysis. Thus by the last time point the communities had approached but 
not completely returned to their pre-treatment states (p<0.005). 
4.5 Discussion 
We report a study of the response of bacterial and fungal communities in the mouse gut 
to antibiotic treatment.  Animals were tracked over 76 days, and sampled densely over this 
period.  Use of both QPCR to assess total abundance and 454/Roche sequencing to quantify 
community structure provided a detailed picture of the effects of antibiotic treatment and 
subsequent recovery on the gut microbiome.   
The bacterial communities initially were dominated by Bacteriodetes and 
Lachnospiraceae, then changed quickly during the antibiotic treatment, reaching a stable state by 
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day two.  At this time, the number of inferred organisms had dropped >3 orders of magnitude, to 
the point that the 16S rRNA gene sequences were mostly transients from food, documenting near 
complete clearance of bacteria from the gut.  Upon cessation of antibiotic treatment, the bacteria 
returned to nearly their original state, though perturbations remained.  The control animals 
remained relatively stable over the time course, dominated by Bacteriodetes and Lachnospiraceae 
throughout.   
Fungal communities changed radically over the time course studied, in association with 
the caging history of the mice.  Even the untreated Control group showed waves of succession 
that differed in each cage.  Cage 1 was first heterogenous, then dominated by Wickerhamomyces, 
then Debaryomyces, then Eurotiales.  Cage 2 was heterogenous through the first six days, then 
dominated by Wickerhamomyces, then again heterogeneous.  These data document a quite 
surprising degree of fungal variation in healthy laboratory mice.    
Previous studies have shown that colonization by specific bacteria in mice can strongly 
influence the outcome of immunological assays [64].  Given the recently reported importance of 
fungi in mouse models of IBD [36], our data suggest that researchers will need to take care to 
monitor and control fungal populations to obtain meaningful data.  The mice in this study were 
housed on a conventional SPF environment.  It would be useful to compare housing in a barrier 
facility where food, water, and bedding have all been sterilized.  Colitis phenotypes in 
genetically-determined mouse models are known to vary in different  facilities, suggesting that it 
will be useful to assess the role of variability in fungal colonization. 
In the presence of antibiotics, the fungal community showed several waves of succession, 
which again differed between cages. Depending on the cage and time point, the communities 
could be heterogeneous, or dominated by Clavispora, Cyberlindnera, Sporopachydermia or 
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Candida.  In cases where communities in a cage were dominated by a single fungal lineage, this 
was true of all mice in the cage at that time point.  One likely explanation is that coprophagia 
resulted in all mice in a single cage acquiring the same fungal colonists.  Some of these fungal 
lineages were seen sporadically in contamination controls (Supplementary Figure 4-6), 
suggesting that gut fungi may have been acquired episodically from the environment.   
Candida was a particularly robust colonist in the presence of antibiotics.  By day 76, all the 
ABXContinuous mice were colonized at a high level exclusively by Candida.  Further supporting 
the robustness of Candida, results from cage two in the ABXShortTerm group by chance 
provides a competition experiment.  Of the five mice analyzed on day two, two were colonized 
with Candida, one with Cyberlindnera, one with Pichia, and one with both Candida and 
Cyberlindnera (Supplementary Figure 4-4, part C).  Coprophagia would presumably allow the 
three species to compete for colonization opportunities.  By day six, all mice were colonized with 
Candida, and this persisted through the cessation of antibiotic treatment by day 22.  At the end of 
the experiment on day 76, Candida was still more abundant in the ABXShortTerm group than 
prior to treatment, all emphasizing that Candida was favored by the antibiotic treatment and 
persisted subsequently. 
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Supplementary Information 
 
Supplementary Figure 4-1. Figure S1.  Comparison of microeukaryote lineages specified by 
the ITS and 18S amplicons.  A)  Heat maps comparing selected samples analyzed using both 
the 18S and ITS amplicons. Each column shows the average for mice in the group and at 
the time point indicated rarefied to 200 reads per individual.  The color code to the right 
indicates the scale.  B)  Procrustes analysis comparing results for the 18S and ITS analysis.  
Data from the 18S and ITS amplicons for each mouse are shown by balls connected by a 
line. 
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Supplementary Figure 4-2.  Heat maps showing the composition of bacterial communities 
inferred from 16S sequence data for each time point (A-I), with each mouse shown 
individually.  The scale of relative proportions is shown on the right. 
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Supplementary Figure 4-3.  16S and ITS sequences recovered from five samples of mouse 
chow.  A)  Sequences from the 16S analysis.  B)  Sequences from the ITS analysis.  The scale 
of relative proportions is shown on the far right.  
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Supplementary Figure 4-4.  Heat maps showing the composition of fungal communities 
inferred from ITS sequence data for each time point (A-G), with each mouse shown 
individually.  The scale of relative proportions is shown on the right. 
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Supplementary Figure 4-5. PCoA analysis distances measures for bacterial (16S sequence 
data) and fungal (ITS sequence data) communities.  Distances matrices were calculated 
using weighted or unweighted UniFrac, then the pairwise distances between a treatment 
group and the control group compared to the  distances within the control group on that 
day.  Asterisks above each box and whisker plot indicate whether the comparison was 
significantly different. 
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Supplementary Figure 4-6. Comparison of contamination controls to experimental samples 
for the 16S A) and ITS B) amplicons.  “Extraction control” indicates sequences derived 
from blank purifications using DNA-free water.  Each column showing mouse data is an 
average over all reads at that time point. 
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  Amount 
ratio (no 
Abx/Abx) 
Average DNA yield no Abx  (ng) 6.10E+02 4.68E+00 
Average DNA yield day 15 Abx (ng) 1.30E+02   
      
Average bacterial genomes no Abx 1.24E+07 9.13E+04 
Average bacterial genomes day 15 Abx 1.35E+02   
      
Average fungal genomes no Abx per pellet 5.95E+03 2.53E-02 
Average fungal gneomes day 15 Abx per pellet 2.35E+05   
      
Average DNA yield no Abx (ng) 6.10E+02 5.65E+00 
Average DNA yield day 76 Abx (ng) 1.08E+02   
      
Average bacterial genomes no Abx per pellet 1.24E+07 3.24E+04 
Average bacterial genomes day 76 Abx per pellet 3.82E+02   
      
Average fungal genomes no Abx 5.95E+03 5.95E-02 
Average fungal gneomes day 76 Abx 1.00E+05   
    Supplementary Table 4-3.  Ratios for DNA yields, average 
bacterial genomes, and average fungal genomes for selected 
comparisons between groups. 
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CHAPTER 5: Conclusions and Future Directions 
 In this dissertation I present novel methods for characterizing understudied clades of the 
gut microbiome and an application that highlights the utility and necessity for such methods. 
Species in the gut interact across domains, forming a single community [1]. Bacteria, archaea, 
and eukarya all contain different metabolic capabilities, which can be strung together to form 
metabolic pathways with different steps taking place in different species. Nevertheless, most 
studies have focused on studying the bacterial community in isolation, which provides a useful 
yet incomplete picture of microbiome dynamics. Subsequently, we developed methods to 
characterize the archaeal and eukaryotic components and explore the selective effects of 
antibiotic treatment across bacterial and eukaryotic gut communities.  
 In Chapter 2, I present a sample-to-analysis pipeline for characterizing microeukaryotic 
communities within the gut microbiome. Development of a targeted assay to study 
microeukaryotes is important, because there is evidence that microeukaryotes, and particularly 
fungi, are underrepresented in metagenomic sequencing assemblies [2]. This method was 
particularly challenging to develop because of the homology between the host genome and the 
genomes of the commensal microeukaryotes. We tested several primers, looking at breadth and 
specificity. Ultimately, 18S rDNA and ITS primers proved to capture their targeted communities 
accurately. The 18S amplicon detected a wide range of fungi and protozoa. The ITS amplicon 
only detected fungi but provided superior differentiation between closely related species. We also 
tested several DNA extraction methods, and determined that harsher lysis methods improve 
fungal DNA yield, as has been corroborated by others [3]. In addition to wet side methods, I also 
developed the BROCC program to automate taxonomic attribution of microeukaryotic sequences 
through voting on high quality, classified BLAST hits.  Ultimately, this work provides a 
framework for future studies of the eukaryotic components of the gut microbiome. 
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 While this study made great strides in understanding the fungal and protozoan gut 
community, community characterization was hampered by poorly curated databases. Specifically, 
many OTUs matched database sequences with high identity, but these database sequences were 
classified only to the phylum or kingdom level (i.e. ‘uncultured fungi’). Many of these sequences 
likely come from understudied microeukaryotic lineages. Recently, several projects have 
produced useful databases characterizing the genomes of eukaryotic species of interest to 
humanity [4,5,6]. The creation of a large amplicon specific database with good coverage of all 
known lineages, particularly of the fungi, for the ITS gene would greatly aid future studies. 
 In Chapter 3, I present a wet lab workup protocol to characterize archaeal communities in 
the gut microbiome. This method was developed through testing different primer pairs, 
thermocycling conditions, and extraction techniques. Through limited Sanger sequencing I found 
Methanobrevibactor in human and macaque samples and Methanobrevibactor, Methanococcus, 
and Thermogymnomonas in murine samples. Previously, archaeal communities were 
characterized indirectly through qPCR [7] or metagenomic shotgun sequencing [8]. These 
techniques are not ideal for community characterization because qPCR does not easily 
differentiate between different species, and metagenomic sequencing is vulnerable to coverage 
related assembly problems [9], which can be exacerbated in rare community members such as 
archaea. The method I developed enables direct determination of the identity of different 
members of an archaeal microbiome community. 
 In this study, we detected the acidophilic genus Thermogymnomonas in stool. As was 
observed in both Chapters 2 and 4, genomic DNA is capable of surviving a trip through the 
digestive tract and being detected in stool.  This is a key observation, because many members of 
the Thermogymnomonas genus and its class Thermoplasmata live between pH 0 and 4 [10,11,12], 
and the type species for the genus Thermogymnomonas acidicola grow optimally at pH 3[13].  
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Yet, species classified as Thermogymnomonas were detected in stool samples which are generally 
thought to be a good representation of the lower GI tract, even though the colon has a pH close to 
7 [14,15]. Subsequently, it is important to determine whether the Thermogymnomonas detected 
was actually inhabiting the colon through some evolutionary adjustments that allow it to survive 
at higher pH levels, or was inhabiting the stomach, with an approximate pH between 1 and 5 
depending on the location and presence of food [16], which would be much more habitable for an 
acidophile. Currently, the only microbe known to commonly inhabit the stomach is Helicobacter 
pylori [17], which can cause ulcers and other gastric disease or live asymptomatically [18]. 
Discovery and characterization of additional stomach microbiome inhabitants could provide more 
information about the causes of gastric disease and aid its treatment. 
 In Chapter 4, I analyze the longitudinal effects of heavy antibiotic use during and after 
treatment in a mouse model using a cocktail of ampicillin, neomycin, vancomycin, and 
metronidazole. We found that this mixture of antibiotics effectively suppresses the commensal 
bacterial community to the point where the only detectable species is Lactococcus lactis, which is 
likely derived from food manufacturing. Eight weeks after antibiotic treatment was stopped, 
many bacterial groups that were common before treatment returned, and cell counts returned to 
their previous levels. However, species composition and diversity were significantly different 
from untreated controls, indicating potential long term perturbation of the bacterial community. 
Under antibiotic treatment, we also observed three species of Saccharomycetales yeasts grow out 
in succession, increasing the fungal genome count by one to two orders of magnitude. After 
cessation of antibiotic treatment, fungal counts returned to normal levels within one week and to 
normal diversity and community composition 8 weeks later compared to untreated controls. 
Unexpectedly we also observed that fungal communities in the controls rapidly change 
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composition without intervention, indicating the fungal gut community is less stable than 
bacterial gut community. 
 The effects of heavy antibiotic use are not well characterized in the human gut. I would 
expect different effects from our findings in Chapter 4 because unlike laboratory mice, most 
humans have had prior antibiotic exposure, and studies have indicated that the human gut is a 
reservoir for antibiotic resistance genes [19]. Heavy antibiotic use may have a less potent effect 
on humans than naïve mice. Also, as we saw in Chapter 2, many of the fungal sequences in 
human studies are suspected to be derived food sources, and it is unclear if these cells are alive 
and viable. Suppression of the bacterial community should cause a fungal outgrowth, but it is 
unknown if Candida albicans, which has been documented to grow out with antibiotic treatment, 
would grow out alone or with other fungi because other yeasts have been documented to grow out 
as well [20]. It would be informative to see if any species that are thought to be food derived 
grow out as well. Species like Saccharomyces cerevisiae have been documented to cause 
infection in rare cases [21], but it is unknown if it is a dynamic member of the gut community.  
 Furthermore, the longitudinal effects of narrower spectrum and single antibiotic 
treatments on the gut microbiota still need to be studied. Many antibiotic regimens prescribed 
today consist of a single antibiotic used for a short time period to resolve acute bacterial infection 
[22]. However, long term side effects have been associated with antibiotic use, such as obesity 
[23].  Understanding the potential long term effects of more typical treatments on the gut 
microbiome may aid clinicians when prescribing antibiotics. 
 This dissertation presents a framework for characterizing understudied clades of the 
microbiome and direct experimentation through use of antibiotics. The methods developed here 
enable researchers to characterize archaea, fungi, and protozoans in microbiome samples. The 
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antibiotic study not only describes the effects of heavy antibiotic treatment on bacterial and 
fungal communities, but it provides a framework for analyzing future antibiotic microbiome 
studies, and highlights the quirks of using such a model, such as detection of bacterial DNA in 
food and observing a succession of fungal species dominate the gut, thereby enabling researchers 
to avoid potential pitfalls. This research can aid a wide variety of future studies of microbial and 
microbiome communities within the fields of microbiology, immunology, and even ecology. 
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APPENDIX 
 
Appendix 1- Plasmids Developed During Thesis Project 
 
      
 
Acession 
Number 
Gene Species 
Plasmid 
Backbone 
 
 
1143 18S-Near Full Candida Topo4 
 
 
1142 18S-Near Full Candida Topo4 
 
 
1145 ITS1, 5.S, and ITS2 Candida Topo4 
 
 
1146 16S -Near Full 
Methanococcus 
maripaludis 
Topo4 
 
 
1147 16S -Near Full Sulfolobus solfataricus Topo4 
 
 
1144 16S-Partial Methanobrevibactor Topo4 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
